UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Number of items: 426.


Abi-Rached, L; Jobin, MJ; Kulkarni, S; Henn, BM; McWhinnie, A; Dalva, K; ... Parham, P; + view all (2011) The shaping of modern human immune systems by multiregional admixture with archaic humans. Science , 334 89 - 94.

Agostinelli, C; Hartmann, S; Klapper, W; Korkolopoulou, P; Righi, S; Marafioti, T; ... Pileri, SA; + view all (2011) Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive. Histopathology , 59 (4) 679 - 691. 10.1111/j.1365-2559.2011.03981.x.

Aguilera, R; Saffie, C; Tittarelli, A; Gonzalez, FE; Ramirez, M; Reyes, D; ... Salazar-Onfray, F; + view all (2011) Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells. CLIN CANCER RES , 17 (8) 2474 - 2483. 10.1158/1078-0432.CCR-10-2384.

Aitchison, KL; Rahim, AA; Hughes, DA; Kinnon, C; Waddington, SN; Howe, SJ; (2011) Lentiviral vectors for gene therapy of Type I Gaucher Disease. HUM GENE THER , 22 (10) A44 - A44.

Aleman, MM; Gardiner, C; Harrison, P; Wolberg, AS; (2011) Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis , 9 , Article 11.

Allay, JA; Sleep, S; Long, S; Tillman, DM; Clark, R; Carney, G; ... Gray, JT; + view all (2011) Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial. HUM GENE THER , 22 (5) 595 - 604. 10.1089/hum.2010.202.

Alvarez-Erviti, L; Seow, Y; Schapira, AH; Gardiner, C; Sargent, IL; Wood, MJA; Cooper, JM; (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. NEUROBIOL DIS , 42 (3) 360 - 367. 10.1016/j.nbd.2011.01.029. Gold open access

Amary, MF; Damato, S; Halai, D; Eskandarpour, M; Berisha, F; Bonar, F; ... Flanagan, AM; + view all (2011) Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet , 43 (12) 1262 - 1265. 10.1038/ng.994.

Anderson, K; Lutz, C; van Delft, FW; Bateman, CM; Guo, YP; Colman, SM; ... Greaves, M; + view all (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. NATURE , 469 (7330) 356 - +. 10.1038/nature09650.

Andrady, C; Sharma, SK; Chester, KA; (2011) Antibody-enzyme fusion proteins for cancer therapy. IMMUNOTHERAPY-UK , 3 (2) 193 - 211. 10.2217/IMT.10.90.

Andrews, PA; Emery, VC; Newstead, C; (2011) Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation. Transplantation , 92 (11) 1181 - 1187. 10.1097/TP.0b013e318235c7fc.

Annenkov, A; Rigby, A; Amor, S; Zhou, D; Yousaf, N; Hemmer, B; Chernajovsky, Y; (2011) A chimeric receptor of the insulin-like growth factor receptor type 1 (IGFR1) and a single chain antibody specific to myelin oligodendrocyte glycoprotein activates the IGF1R signalling cascade in CG4 oligodendrocyte progenitors. Biochim Biophys Acta , 1813 (8) 1428 - 1437. 10.1016/j.bbamcr.2011.04.006.

Anoop, P; Shaw, BE; Riley, U; Ethell, ME; Taj, M; Lancaster, DL; ... Potter, MN; + view all (2011) Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis. HEMATOLOGY , 16 (4) 213 - 220. 10.1179/102453311X13025568941763.

Antoniou, AN; Guiliano, DB; Lenart, I; Burn, G; Powis, SJ; (2011) The Oxidative Folding and Misfolding of Human Leukocyte Antigen-B27. ANTIOXID REDOX SIGN , 15 (3) 669 - 684. 10.1089/ars.2010.3692.

Arkenau, HK; (2011) Capecitabine combined with oxaliplatin (CAPOX) in clinical practice: how significant is peripheral neuropathy? Ann Oncol , 22 (1) 239 - 240. 10.1093/annonc/mdq676.

Arkenau, HT; Kefford, R; Long, GV; (2011) Targeting BRAF for patients with melanoma. Br J Cancer , 104 (3) 392 - 398. 10.1038/sj.bjc.6606030.

Arkenau, HT; Nordman, I; Dobbins, T; Ward, R; (2011) Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer. Cancer , 117 (4) 832 - 840. 10.1002/cncr.25636.

Arthold, S; Kurowski, A; Wutz, A; (2011) Mechanistic insights into chromosome-wide silencing in X inactivation. Hum Genet , 130 (2) 295 - 305. 10.1007/s00439-011-1002-0.

Atkinson, C; Emery, VC; (2011) Cytomegalovirus quantification: Where to next in optimising patient management? J CLIN VIROL , 51 (4) 219 - 224. 10.1016/j.jcv.2011.04.007.

Averbuch, D; Chapgier, A; Boisson-Dupuis, S; Casanova, JL; Engelhard, D; (2011) The clinical spectrum of patients with deficiency of Signal Transducer and Activator of Transcription-1. Pediatr Infect Dis J , 30 (4) 352 - 355. 10.1097/INF.0b013e3181fdff4a.

Babu, B; Lee, M; Lee, L; Strobel, R; Brockway, O; Nickols, A; ... Lee, M; + view all (2011) Acetyl analogs of combretastatin A-4: Synthesis and biological studies. BIOORGAN MED CHEM , 19 (7) 2359 - 2367. 10.1016/j.bmc.2011.02.018.

Babu, B; Liu, Y; Plaunt, A; Riddering, C; Ogilvie, R; Westrate, L; ... Lee, M; + view all (2011) Design, synthesis and DNA binding properties of orthogonally positioned diamino containing polyamide f-IPI. BIOCHEM BIOPH RES CO , 404 (3) 848 - 852. 10.1016/j.bbrc.2010.12.073.

Bafadhel, M; McKenna, S; Terry, S; Mistry, V; Reid, C; Haldar, P; ... Brightling, CE; + view all (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med , 184 (6) 662 - 671. 10.1164/rccm.201104-0597OC.

Bakke, PS; Zhu, G; Gulsvik, A; Kong, X; Agusti, AG; Calverley, PM; ... Pillai, SG; + view all (2011) Candidate genes for COPD in two large data sets. Eur Respir J , 37 (2) 255 - 263. 10.1183/09031936.00091709.

Ballingall, KT; Herrmann-Hoesing, L; Robinson, J; Marsh, SGE; Stear, MJ; (2011) A single nomenclature and associated database for alleles at the MHC class II DRB1 locus of sheep: IPD-MHC OLA. Tissue Antigens , 77 546 - 553. 10.1111/j.1399-0039.2011.01637.x.

Baraniskin, A; Munding, J; Schulmann, K; Meier, D; Porschen, R; Arkenau, HT; ... Reinacher-Schick, A; + view all (2011) Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Clin Colorectal Cancer , 10 (1) 24 - 29. 10.3816/CCC.2011.n.003.

Bateman, A; Agrawal, S; Birney, E; Bruford, EA; Bujnicki, JM; Cochrane, G; ... Zwieb, C; + view all (2011) RNAcentral: A vision for an international database of RNA sequences. RNA , 17 (11) 1941 - 1946. 10.1261/rna.2750811.

Bates, AW; (2011) The anatomy of beauty in nineteenth-century England. Hektoen International , 3 (1)

Bell, CG; (2011) Accessing and selecting genetic markers from available resources. Methods Mol Biol , 760 1 - 17. 10.1007/978-1-61779-176-5_1.

Bell, CG; (2011) Integration of genomic and epigenomic DNA methylation data in common complex diseases by haplotype-specific methylation analysis. PERS MED , 8 (3) 243 - 251. 10.2217/PME.11.14.

Beltran, L; Chaussade, C; Vanhaesebroeck, B; Cutillas, PR; (2011) Calpain interacts with class IA phosphoinositide 3-kinases regulating their stability and signaling activity. Proc Natl Acad Sci U S A , 108 (39) 16217 - 16222. 10.1073/pnas.1107692108.

Bennett, CL; Fallah-Arani, F; Conlan, T; Trouillet, C; Goold, H; Chorro, L; ... Chakraverty, R; + view all (2011) Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin. BLOOD , 117 (26) 7063 - 7069. 10.1182/blood-2011-01-329185.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; ... Nathwani, A; + view all (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Binny, C; McIntosh, J; Peruta, M; Kymalainen, H; Tuddenham, E; Waddington, S; ... Nathwani, A; + view all (2011) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous haemorrhage. HUMAN GENE THERAPY , 22 (10) A45 - A45.

Birkbak, NJ; Eklund, AC; Li, Q; McClelland, SE; Endesfelder, D; Tan, P; ... Swanton, C; + view all (2011) Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res , 71 (10) 3447 - 3452. 10.1158/0008-5472.CAN-10-3667.

Bochtler, W; Maiers, M; Bakker, JNA; Oudshoorn, M; Marsh, SGE; Baier, D; ... Muller, CR; + view all (2011) World Marrow Donor Association framework for the implementation of HLA matching programs in hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant , 46 338 - 343.

Bolli, N; Payne, EM; Rhodes, J; Gjini, E; Johnston, AB; Guo, F; ... Look, AT; + view all (2011) cpsf1 is required for definitive HSC survival in zebrafish. Blood , 117 (15) 3996 - 4007. 10.1182/blood-2010-08-304030.

Boo, M; van Walraven, SM; Chapman, J; Lindberg, B; Schmidt, AH; Shaw, BE; ... World Marrow Donor Assoc,; + view all (2011) Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association. BLOOD , 117 (1) 21 - 25. 10.1182/blood-2010-07-298430.

Bramham, K; Hilton, R; Horsfield, C; McDonald, V; Camilleri, R; Hunt, BJ; (2011) ADAMTS-13 deficiency: can it cause chronic renal failure? Nephrol Dial Transplant , 26 (2) 742 - 744. 10.1093/ndt/gfq644.

Brehm, JM; Hagiwara, K; Tesfaigzi, Y; Bruse, S; Mariani, TJ; Bhattacharya, S; ... Celedón, JC; + view all (2011) Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease. Thorax , 66 (12) 1085 - 1090. 10.1136/thoraxjnl-2011-200017.

Briesemeister, D; Sommermeyer, D; Loddenkemper, C; Loew, R; Uckert, W; Blankenstein, T; Kammertoens, T; (2011) Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis. INT J CANCER , 128 (2) 371 - 378. 10.1002/ijc.25350.

Brough, R; Frankum, JR; Sims, D; Mackay, A; Mendes-Pereira, AM; Bajrami, I; ... Ashworth, A; + view all (2011) Functional viability profiles of breast cancer. Cancer Discov , 1 (3) 260 - 273. 10.1158/2159-8290.CD-11-0107.

Brucoli, F; Hawkins, RM; James, CH; Wells, G; Jenkins, TC; Ellis, T; ... Thurston, DE; + view all (2011) Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. BIOORG MED CHEM LETT , 21 (12) 3780 - 3783. 10.1016/j.bmcl.2011.04.054.

Brunetto, A; Olmos, D; Arkenau, HT; Tan, D; Yap, T; de Bono, J; ... Kaye, S; + view all (2011) Perceptions and referral trends into phase I oncology trials: results of a clinical survey. J Oncol , 2011 861401 - ?. 10.1155/2011/861401.

Bustamante, J; Arias, AA; Vogt, G; Picard, C; Galicia, LB; Prando, C; ... Casanova, JL; + view all (2011) Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol , 12 (3) 213 - 221. 10.1038/ni.1992.

Calabretta, B; Salomoni, P; (2011) Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors. LEUKEMIA LYMPHOMA , 52 54 - 59. 10.3109/10428194.2010.546913.

Calleja-Agius, J; Muttukrishna, S; Pizzey, AR; Jauniaux, E; (2011) Pro- and antiinflammatory cytokines in threatened miscarriages. Am J Obstet Gynecol , 205 (1) 83.e8 - 83.16. 10.1016/j.ajog.2011.02.051.

Calvert, H; Azzariti, A; (2011) The clinical development of inhibitors of poly(ADP-ribose) polymerase. ANNALS OF ONCOLOGY , 22 i53 - i59. 10.1093/annonc/mdq667.

Cantu, C; Ierardi, R; Alborelli, I; Fugazza, C; Cassinelli, L; Piconese, S; ... Ronchi, A; + view all (2011) Sox6 enhances erythroid differentiation in human erythroid progenitors. BLOOD , 117 (13) 3669 - 3679. 10.1182/blood-2010-04-282350.

Cappellini, MD; Bejaoui, M; Agaoglu, L; Canatan, D; Capra, M; Cohen, A; ... Aydinok, Y; + view all (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. BLOOD , 118 (4) 884 - 893. 10.1182/blood-2010-11-316646.

Carlin, LM; Evans, R; Milewicz, H; Fernandes, L; Matthews, DR; Perani, M; ... Ng, T; + view all (2011) A Targeted siRNA Screen Identifies Regulators of Cdc42 Activity at the Natural Killer Cell Immunological Synapse. Science Signaling , 4 (201) ra81 - ra81. 10.1126/scisignal.2001729.

Carpenter, L; Malladi, R; Yang, CT; French, A; Pilkington, KJ; Forsey, RW; ... Watt, SM; + view all (2011) Human induced pluripotent stem cells are capable of B-cell lymphopoiesis. BLOOD , 117 (15) 4008 - 4011. 10.1182/blood-2010-08-299941.

Casper, CJ; Warner, TT; Taanman, JW; Nathwani, AC; (2011) Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. HUMAN GENE THERAPY , 22 (10) A42 - A43.

Castaldi, PJ; Cho, MH; Litonjua, AA; Bakke, P; Gulsvik, A; Lomas, DA; ... COPDGene and Eclipse Investigators,; + view all (2011) The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol , 45 (6) 1147 - 1153. 10.1165/rcmb.2011-0055OC.

Castaldi, PJ; Demeo, DL; Hersh, CP; Lomas, DA; Soerheim, IC; Gulsvik, A; ... Silverman, EK; + view all (2011) Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax , 66 (10) 903 - 909. 10.1136/thx.2010.146118.

Catlin, SN; Busque, L; Gale, RE; Guttorp, P; Abkowitz, JL; (2011) The replication rate of human hematopoietic stem cells in vivo. BLOOD , 117 (17) 4460 - 4466. 10.1182/blood-2010-08-303537.

Cerone, MA; Burgess, DJ; Naceur-Lombardelli, C; Lord, CJ; Ashworth, A; (2011) High-throughput RNAi screening reveals novel regulators of telomerase. Cancer Res , 71 (9) 3328 - 3340. 10.1158/0008-5472.CAN-10-2734.

Chakraverty, R; Mackinnon, S; (2011) Allogeneic Transplantation for Lymphoma. J CLIN ONCOL , 29 (14) 1855 - 1863. 10.1200/JCO.2010.32.8419.

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; ... Lee, M; + view all (2011) Hx, a Novel Fluorescent, Minor Groove and Sequence Specific Recognition Element: Design, Synthesis, and DNA Binding Properties of p-Anisylbenzimidazole-imidazole/pyrrole-Containing Polyamides. BIOCHEMISTRY-US , 50 (15) 3127 - 3136. 10.1021/bi102028a.

Chew, SK; Rad, R; Futreal, PA; Bradley, A; Liu, P; (2011) Genetic screens using the piggyBac transposon. Methods , 53 (4) 366 - 371. 10.1016/j.ymeth.2010.12.022.

Confer, DL; Shaw, BE; Pamphilon, DH; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. Bone Marrow Transplantation , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Confer, DL; Shaw, BE; Pamphilon, DH; Clinical Working Grp WMDA,; (2011) WMDA guidelines for subsequent donations following initial BM or PBSCs. BONE MARROW TRANSPL , 46 (11) 1409 - 1412. 10.1038/bmt.2010.323.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Downstream of human NDR kinases Impacting on c-myc and p21 protein stability to control cell cycle progression. CELL CYCLE , 10 (12) 1897 - 1904. 10.4161/cc.10.12.15826.

Cornils, H; Kohler, RS; Hergovich, A; Hemmings, BA; (2011) Human NDR Kinases Control G(1)/S Cell Cycle Transition by Directly Regulating p21 Stability. MOL CELL BIOL , 31 (7) 1382 - 1395. 10.1128/MCB.01216-10.

Cortese, R; Lewin, J; Backdahl, L; Krispin, M; Wasserkort, R; Eckhardt, F; Beck, S; (2011) Genome-Wide Screen for Differential DNA Methylation Associated with Neural Cell Differentiation in Mouse. PLOS ONE , 6 (10) , Article e26002. 10.1371/journal.pone.0026002. Green open access

Coward, J; Kulbe, H; Chakravarty, P; Leader, D; Vassileva, V; Leinster, DA; ... Balkwill, FR; + view all (2011) Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer. CLIN CANCER RES , 17 (18) 6083 - 6096. 10.1158/1078-0432.CCR-11-0945.

Cox, ST; Stephens, HA; Fernando, R; Karasu, A; Harber, M; Howie, AJ; ... Little, AM; + view all (2011) Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation. Hum Immunol , 72 (10) 827 - 834. 10.1016/j.humimm.2011.05.004.

Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S; (2011) Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition. J BIOL CHEM , 286 (11) 9713 - 9725. 10.1074/jbc.M110.173872. Gold open access

David, AL; McIntosh, J; Peebles, DM; Cook, T; Waddington, S; Weisz, B; ... Nathwani, AC; + view all (2011) Recombinant Adeno-Associated Virus-Mediated In Utero Gene Transfer Gives Therapeutic Transgene Expression in the Sheep. HUM GENE THER , 22 (4) 419 - 426. 10.1089/hum.2010.007.

De Bono, JS; Logothetis, CJ; Molina, A; Fizazi, K; North, S; Chu, L; ... COU-AA-301 Investigators,; + view all (2011) Abiraterone and Increased Survival in Metastatic Prostate Cancer. NEW ENGL J MED , 364 (21) 1995 - 2005.

De Gobbi, M; Garrick, D; Lynch, M; Vernimmen, D; Hughes, JR; Goardon, N; ... Higgs, DR; + view all (2011) Generation of bivalent chromatin domains during cell fate decisions. EPIGENET CHROMATIN , 4 , Article 9. 10.1186/1756-8935-4-9. Gold open access

Dedes, KJ; Wetterskog, D; Ashworth, A; Kaye, SB; Reis-Filho, JS; (2011) Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol , 8 (5) 261 - 271. 10.1038/nrclinonc.2010.216.

Dedes, KJ; Wilkerson, PM; Wetterskog, D; Weigelt, B; Ashworth, A; Reis-Filho, JS; (2011) Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell Cycle , 10 (8) 1192 - 1199.

Della Peruta, M; Binny, C; Nathwani, D; Chokshi, S; McIntosh, J; Rosales, C; ... Nathwani, AC; + view all (2011) The development of a tumour-selective recombinant adeno-associated virus vector to target hepatocellular carcinoma. HUMAN GENE THERAPY , 22 (10) A113 - A113.

Denbo, JW; Williams, RF; Orr, WS; Sims, TL; Ng, CY; Zhou, JF; ... Davidoff, AM; + view all (2011) Continuous local delivery of interferon-beta stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection model. SURGERY , 150 (3) 497 - 504. 10.1016/j.surg.2011.07.044.

Deugnier, Y; Turlin, B; Ropert, M; Cappellini, MD; Porter, JB; Giannone, V; ... Brissot, P; + view all (2011) Improvement in Liver Pathology of Patients With beta-Thalassemia Treated With Deferasirox for at Least 3 Years. GASTROENTEROLOGY , 141 (4) 1202 - U618. 10.1053/j.gastro.2011.06.065.

Dickens, JA; Lomas, DA; (2011) Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. Drug Des Devel Ther , 5 391 - 405. 10.2147/DDDT.S14018.

Dickens, JA; Miller, BE; Edwards, LD; Silverman, EK; Lomas, DA; Tal-Singer, R; Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators,; (2011) COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res , 12 146 - ?. 10.1186/1465-9921-12-146.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) Reply to: The danger to cytopathology of overspecialization and its relevance for histopathology Authors' response. CYTOPATHOLOGY , 22 (3) 209 - 210. 10.1111/j.1365-2303.2011.00875.x.

Dina, R; Gudi, M; Kocjan, G; Schmitt, F; Vielh, P; (2011) The danger to cytopathology of over-specialization and its relevance for histopathology. CYTOPATHOLOGY , 22 (2) 140 - 140. 10.1111/j.1365-2303.2011.00865.x.

Dragovic, RA; Gardiner, C; Brooks, AS; Tannetta, DS; Ferguson, DJ; Hole, P; ... others,; + view all (2011) Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine: nanotechnology, biology, and medicine

Drew, Y; Ledermann, JA; Jones, A; Hall, G; Jayson, GC; Highley, M; ... Plummer, ER; + view all (2011) Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

du Parcq, PA; Jones, P; Nelson, J; Miller, K; Diss, T; (2011) EGFR mutation in non-small cell lung cancer: one year of laboratory testing. LUNG CANCER , 71 S3 - S3.

Duarte, RF; Shaw, BE; Marin, P; Kottaridis, P; Ortiz, M; Morante, C; ... Russell, NH; + view all (2011) Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. BONE MARROW TRANSPL , 46 (1) 52 - 58. 10.1038/bmt.2010.54.

Dudderidge, TJ; Kelly, J; Wollenschlaeger, A; Leung, H; Okoturo, O; Prevost, T; ... Chromosomal Replicat Grp,; + view all (2011) DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE. EUR UROL SUPPL , 10 (2) 73 - 74.

Duvoix, A; Miranda, E; Perez, J; Sorensen, GL; Holmskov, U; Trapnell, BC; ... Lomas, DA; + view all (2011) Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD. COPD , 8 (2) 79 - 95. 10.3109/15412555.2011.558542.

Ekeowa, UI; Marciniak, SJ; Lomas, DA; (2011) α(1)-antitrypsin deficiency and inflammation. Expert Rev Clin Immunol , 7 (2) 243 - 252. 10.1586/eci.10.95.

Elliott, P; Baker, R; Pasquale, F; Quarta, G; Ebrahim, H; Mehta, AB; ... ACES Study Grp,; + view all (2011) Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. HEART , 97 (23) 1957 - 1960. 10.1136/heartjnl-2011-300364.

Emery, VC; (2011) Could a vaccine against immune-evading cytomegalovirus become a reality? Expert Rev Vaccines , 10 (8) 1109 - 1111. 10.1586/erv.11.92.

Emery, VC; Einsele, H; Atabani, S; Haque, T; (2011) Immunotherapy and Vaccination After Transplant: The Present, the Future. HEMATOL ONCOL CLIN N , 25 (1) 215 - +. 10.1016/j.hoc.2010.11.014.

Endesfelder, D; McGranahan, N; Birkbak, NJ; Szallasi, Z; Kschischo, M; Graham, TA; Swanton, C; (2011) A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables. Oncotarget , 2 (7) 529 - 537.

Evans, P; Cindrova-Davies, T; Muttukrishna, S; Burton, GJ; Porter, J; Jauniaux, E; (2011) Hepcidin and iron species distribution inside the first-trimester human gestational sac. MOL HUM REPROD , 17 (4) 227 - 232. 10.1093/molehr/gaq101.

Feber, A; Xi, LQ; Pennathur, A; Gooding, WE; Bandla, S; Wu, MX; ... Litle, VR; + view all (2011) MicroRNA Prognostic Signature for Nodal Metastases and Survival in Esophageal Adenocarcinoma. ANNALS OF THORACIC SURGERY , 91 (5) 1523 - 1530. 10.1016/j.athoracsur.2011.01.056.

Feng, G; Nadig, SN; Backdahl, L; Beck, S; Francis, RS; Schiopu, A; ... Bushell, A; + view all (2011) Functional Regulatory T Cells Produced by Inhibiting Cyclic Nucleotide Phosphodiesterase Type 3 Prevent Allograft Rejection. SCI TRANSL MED , 3 (83) , Article 83ra40. 10.1126/scitranslmed.3002099.

Feng, H; Hu, B; Liu, KW; Li, Y; Lu, X; Cheng, T; ... Cheng, SY; + view all (2011) Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans. J Clin Invest , 121 (12) 4670 - 4684. 10.1172/JCI58559.

Fenton, TR; Gout, IT; (2011) Functions and regulation of the 70 kDa ribosomal S6 kinases. INT J BIOCHEM CELL B , 43 (1) 47 - 59. 10.1016/j.bioce1.2010.09.018.

Fernandes, E; Goold, HD; Kissenpfennig, A; Malissen, B; Dyson, J; Bennett, CL; (2011) The Role of Direct Presentation by Donor Dendritic Cells in Rejection of Minor Histocompatibility Antigen-Mismatched Skin and Hematopoietic Cell Grafts. TRANSPLANTATION , 91 (2) 154 - 160. 10.1097/TP.0b013e318201ac27.

Fielding, AK; (2011) Current therapeutic strategies in adult acute lymphoblastic leukemia. Hematol Oncol Clin North Am , 25 (6) 1255 - viii. 10.1016/j.hoc.2011.09.008.

Fielding, AK; (2011) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program , 2011 231 - 237. 10.1182/asheducation-2011.1.231.

Fielding, AK; (2011) Philadelphia-Positive Acute Lymphoblastic Leukemia-Is Bone Marrow Transplant Still Necessary? BIOL BLOOD MARROW TR , 17 (1) S84 - S88. 10.1016/j.bbmt.2010.11.023.

Flicek, P; Amode, MR; Barrell, D; Beal, K; Brent, S; Chen, Y; ... Searle, SM; + view all (2011) Ensembl 2011. Nucleic Acids Res , 39 (Database issue) D800 - D806. 10.1093/nar/gkq1064.

Flutter, B; Velica, P; Chakraverty, R; (2011) Memory lapses in graft-versus-host disease. EUR J IMMUNOL , 41 (9) 2530 - 2534. 10.1002/eji.201141946.

Foley, JH; Cook, PF; Nesheim, ME; (2011) Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites. Journal of Biological Chemistry , 286 (22) 19280 - 19286. 10.1074/jbc.M110.215061.

Foreman, MG; Kong, X; DeMeo, DL; Pillai, SG; Hersh, CP; Bakke, P; ... Silverman, EK; + view all (2011) Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol , 44 (3) 316 - 322. 10.1165/rcmb.2009-0360OC.

Forster, MD; Dedes, KJ; Sandhu, S; Frentzas, S; Kristeleit, R; Ashworth, A; ... Molife, LR; + view all (2011) Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol , 8 (5) 302 - 306. 10.1038/nrclinonc.2011.42.

Furuse, J; Okusaka, T; Bridgewater, J; Taketsuna, M; Wasan, H; Koshiji, M; Valle, J; (2011) Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. Crit Rev Oncol Hematol , 80 (1) 31 - 39. 10.1016/j.critrevonc.2010.10.009.

Gal, A; Hughes, DA; Winchester, B; (2011) Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J INHERIT METAB DIS , 34 (2) 509 - 514. 10.1007/s10545-010-9261-9.

Gardiner, C; Tannetta, DS; Simms, CA; Harrison, P; Redman, CWG; Sargent, IL; (2011) Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PloS one , 6 , Article 10.

Garstka, MA; Fritzsche, S; Lenart, I; Hein, Z; Jankevicius, G; Boyle, LH; ... Springer, S; + view all (2011) Tapasin dependence of major histocompatibility complex class I molecules correlates with their conformational flexibility. FASEB J , 25 (11) 3989 - 3998. 10.1096/fj.11-190249.

Gómez-López, S; Wiskow, O; Favaro, R; Nicolis, SK; Price, DJ; Pollard, SM; Smith, A; (2011) Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells In vitro. Glia , 59 (11) 1588 - 1599. 10.1002/glia.21201.

Gerrard, G; Mudge, K; Stewart, R; Foskett, P; Stevens, D; Khorashad, JS; ... Foroni, L; + view all (2011) Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies. Am J Hematol , 86 (3) 313 - 315. 10.1002/ajh.21954.

Goardon, N; Marchi, E; Atzberger, A; Quek, L; Schuh, A; Soneji, S; ... Vyas, P; + view all (2011) Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia. CANCER CELL , 19 (1) 138 - 152. 10.1016/j.ccr.2010.12.012.

Goldstein, R; Meyer, T; (2011) Role of everolimus in pancreatic neuroendocrine tumors. Expert Rev Anticancer Ther , 11 (11) 1653 - 1665. 10.1586/era.11.145.

Grabher, C; Payne, EM; Johnston, AB; Bolli, N; Lechman, E; Dick, JE; ... Look, AT; + view all (2011) Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. Leukemia , 25 (3) 506 - 514. 10.1038/leu.2010.280.

Gravel, S; Henn, BM; Gutenkunst, RN; Indap, AR; Marth, GT; Clark, AG; ... McVean, GA; + view all (2011) Demographic history and rare allele sharing among human populations. Proceedings of the National Academy of Sciences , 108 (29) 11983 - 11988. 10.1073/pnas.1019276108.

Grimmett, C; Bridgewater, J; Steptoe, A; Wardle, J; (2011) Lifestyle and quality of life in colorectal cancer survivors. QUAL LIFE RES , 20 (8) 1237 - 1245. 10.1007/s11136-011-9855-1.

Gunaratnam, M; de la Fuente, M; Hampel, SM; Todd, AK; Reszka, AP; Schätzlein, A; Neidle, S; (2011) Targeting pancreatic cancer with a G-quadruplex ligand. Bioorg Med Chem , 19 (23) 7151 - 7157. 10.1016/j.bmc.2011.09.055.

Gutierrez, A; Grebliunaite, R; Feng, H; Kozakewich, E; Zhu, S; Guo, F; ... Look, AT; + view all (2011) Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med , 208 (8) 1595 - 1603. 10.1084/jem.20101691.

Hackshaw, A; Kirkwood, A; (2011) Interpreting and reporting clinical trials with results of borderline significance. BMJ , 343 d3340 - ?.

Hackshaw, A; Rodeck, C; Boniface, S; (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. HUM REPROD UPDATE , 17 (5) 589 - 604. 10.1093/humupd/dmr022. Gold open access

Harrison, P; Mackie, I; Mumford, A; Briggs, C; Liesner, R; Winter, M; ... British Comm Stand Haematology,; + view all (2011) Guidelines for the laboratory investigation of heritable disorders of platelet function. BRIT J HAEMATOL , 155 (1) 30 - 44. 10.1111/j.1365-2141.2011.08793.x.

Hartley, JA; (2011) The development of pyrrolobenzodiazepines as antitumour agents. EXPERT OPIN INV DRUG , 20 (6) 733 - 744. 10.1517/13543784.2011.573477.

Hartley, JM; Spanswick, VJ; Hartley, JA; (2011) Measurement of DNA damage in individual cells using the Single Cell Gel Electrophoresis (Comet) assay. Methods Mol Biol , 731 309 - 320. 10.1007/978-1-61779-080-5_25.

Hartmann, S; Agostinelli, C; Klapper, W; Korkolopoulou, P; Koch, K; Marafioti, T; ... Hansmann, ML; + view all (2011) Revising the historical collection of epithelioid cell-rich lymphomas of the Kiel Lymph Node Registry: what is Lennert's lymphoma nowadays? Histopathology , 59 (6) 1173 - 1182. 10.1111/j.1365-2559.2011.04069.x.

Haylock-Jacobs, S; Comerford, I; Bunting, M; Kara, E; Townley, S; Klingler-Hoffmann, M; ... McColl, SR; + view all (2011) PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun , 36 (3-4) 278 - 287. 10.1016/j.jaut.2011.02.006.

Heneghan, C; Ward, A; Perera, R; (2011) Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. The Lancet

Hergovich, A; (2011) MOB control: Reviewing a conserved family of kinase regulators. CELL SIGNAL , 23 (9) 1433 - 1440. 10.1016/j.cellsig.2011.04.007.

Hersh, CP; Silverman, EK; Gascon, J; Bhattacharya, S; Klanderman, BJ; Litonjua, AA; ... Mariani, TJ; + view all (2011) SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development. Am J Respir Crit Care Med , 183 (11) 1482 - 1489. 10.1164/rccm.201010-1751OC.

Herzog, RW; Davidoff, AM; Markusic, DM; Nathwani, AC; (2011) AAV Vector Biology in Primates: Finding the Missing Link? MOL THER , 19 (11) 1923 - 1924. 10.1038/mt.2011.218.

Hiwarkar, P; Shaw, BE; Tredger, JM; Brown, NW; Kulkarni, S; Saso, R; ... Potter, MN; + view all (2011) Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. CLIN TRANSPLANT , 25 (2) 222 - 227. 10.1111/j.1399-0012.2010.01226.x.

Hochdörfer, T; Kuhny, M; Zorn, CN; Hendriks, RW; Vanhaesebroeck, B; Bohnacker, T; ... Huber, M; + view all (2011) Activation of the PI3K pathway increases TLR-induced TNF-α and IL-6 but reduces IL-1β production in mast cells. Cell Signal , 23 (5) 866 - 875. 10.1016/j.cellsig.2011.01.012.

Hollenbach, JA; Mack, SJ; Gourraud, PA; Single, RM; Maiers, M; Middleton, D; ... Varney, MD; + view all (2011) A community standard for immunogenomic data-reporting and analysis: Proposal for a STrengthening the REporting of Immunogenomic Studies (STREIS) statement. Tissue Antigens , 78 333 - 344.

Holme, H; Nanduri, V; (2011) Superior vena cava obstruction: dangers of a missed diagnosis. J Paediatr Child Health , 47 (3) 150 - 151. 10.1111/j.1440-1754.2010.01741.x.

Howie, AJ; (2011) Problems with 'focal segmental glomerulosclerosis'. Pediatr Nephrol , 26 (8) 1197 - 1205. 10.1007/s00467-010-1701-0.

Hughes, D; (2011) Gaucher disease: hematologic and oncologic implications. Clin Adv Hematol Oncol , 9 (10) 771 - 772.


Hughes, DA; Al-Sayed, M; Belmatoug, N; Bodamer, O; Bottcher, T; Cappellini, M; ... Weinreb, N; + view all (2011) Early access experience with VPRIV (R): Recommendations for 'core data' collection. BLOOD CELL MOL DIS , 47 (2) 140 - 142. 10.1016/j.bcmd.2010.10.015.

Hughes, DA; Romero, MAB; Hollak, CEM; Giugliani, R; Deegan, PB; FOS Investigators,; (2011) Response of women with Fabry disease to enzyme replacement therapy: Comparison with men, using data from FOS-the Fabry Outcome Survey. MOL GENET METAB , 103 (3) 207 - 214. 10.1016/j.ymgme.2011.03.022.

Ibrahim, AR; Eliasson, L; Apperley, JF; Milojkovic, D; Bua, M; Szydlo, R; ... Marin, D; + view all (2011) Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy. Blood , 117 (14) 3733 - 3736. 10.1182/blood-2010-10-309807.

Ibrahim, M; Dodson, A; O'Grady, T; Parry, S; Miller, K; Doolan, C; Jasani, B; (2011) HER2 ICC Web-based interpretive scheme: a pilot study by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S73 - S74.

Ibrahim, M; Herriott, K; Parry, S; Miller, K; (2011) Audit of breast biomarkers markers, HER2.ER & PR in the UK: an update by the UK National External Quality Assessment Scheme for Immunocytochemistry and In Situ Hybridisation (UK NEQAS ICC & ISH). VIRCHOWS ARCH , 459 S74 - S74.

Ibrahim, M; Parry, S; Miller, K; (2011) Immunocytochemical staining of breast biomarkers HER2, ER and PR; potential pitfalls of false positive/negative staining: findings of the UK NEQAS ICC & ISH. VIRCHOWS ARCH , 459 S74 - S74.

Iorio, M; Piovan, C; Di Leva, G; Palmieri, D; Casalini, P; Braccioli, L; ... Tagliabue, E; + view all (2011) Breast cancer and microRNAs: Therapeutic impact. BREAST , 20 S6 - S6.

Jahn, TR; Kohlhoff, KJ; Scott, M; Tartaglia, GG; Lomas, DA; Dobson, CM; ... Crowther, DC; + view all (2011) Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease. J Neurosci Methods , 197 (1) 186 - 189. 10.1016/j.jneumeth.2011.01.026.

Jennings, BH; (2011) Drosophila - a versatile model in biology & medicine. MATER TODAY , 14 (5) 190 - 195. Gold open access

Johansson, AM; Karlsson, MO; Standing, JF; Hill, N; Perisoglou, M; Whelan, J; (2011) A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma. Therapeutic Drug Monitoring , 33 (6) 711 - 718. 10.1097/FTD.0b013e31823615e1.

Juergens, H; Daw, NC; Geoerger, B; Ferrari, S; Villarroel, M; Aerts, I; ... Gualberto, A; + view all (2011) Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma. J Clin Oncol , 29 (34) 4534 - 4540. 10.1200/JCO.2010.33.0670.

Kanga, U; McWhinnie, AJ; Mourya, M; Shaw, BE; Madrigal, JA; Mehra, NK; (2011) A novel HLA-DPB1 allele, DPB1*125:01, identified by sequence-based typing in an Indian individual. TISSUE ANTIGENS , 77 (1) 85 - 87. 10.1111/j.1399-0039.2010.01562.x.

Kasperavičiute, D; Catarino, CB; Chinthapalli, K; Clayton, LMS; Thom, M; Martinian, L; ... Sisodiya, SM; + view all (2011) Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare microdeletions. PLoS ONE , 6 (8) , Article e23182. 10.1371/journal.pone.0023182. Green open access

Kato, H; Seto, K; Kobayashi, N; Yoshinaga, K; Meyer, T; Takei, M; (2011) CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells. LIFE SCI , 89 (17-18) 603 - 608. 10.1016/j.lfs.2011.07.019.

Kautz-Neu, K; Noordegraaf, M; Dinges, S; Bennett, CL; John, D; Clausen, BE; von Stebut, E; (2011) Langerhans cells are negative regulators of the anti-leishmania response. Journal of Experimental Medicine , 208 (5) 885 - 91. 10.1084/jem.20102318.

Kepp, O; Galluzzi, L; Martins, I; Schlemmer, F; Adjemian, S; Michaud, M; ... Kroemer, G; + view all (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev , 30 (1) 61 - 69. 10.1007/s10555-011-9273-4.

Khwaja, A; (2011) PI3K as a Target for Therapy in Haematological Malignancies. CURR TOP MICROBIOL , 347 169 - 188. 10.1007/82_2010_71.

Kimata, Y; Kitamura, K; Fenner, N; Yamano, H; (2011) Mes1 controls the meiosis I to meiosis II transition by distinctly regulating the anaphase-promoting complex/cyclosome coactivators Fzr1/Mfr1 and Slp1 in fission yeast. MOL BIOL CELL , 22 (9) 1486 - 1494. 10.1091/mbc.E10-09-0774. Gold open access

King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; ... Egeland, T; + view all (2011) Unrelated hematopoietic stem cell donors as research subjects. Bone Marrow Transplantation , 46 (1) 10 - 13. 10.1038/bmt.2010.37.

Kistler, AD; Siwy, J; Breunig, F; Jeevaratnam, P; Scherl, A; Mullen, W; ... Serra, AL; + view all (2011) A Distinct Urinary Biomarker Pattern Characteristic of Female Fabry Patients That Mirrors Response to Enzyme Replacement Therapy. PLOS ONE , 6 (6) , Article e20534. 10.1371/journal.pone.0020534. Green open access

Kocjan, G; Chandra, A; Cross, PA; Giles, T; Johnson, SJ; Stephenson, TJ; ... Poller, DN; + view all (2011) The Interobserver Reproducibility of Thyroid Fine-Needle Aspiration Using the UK Royal College of Pathologists' Classification System. AM J CLIN PATHOL , 135 (6) 852 - 859. 10.1309/AJCPZ33MVMGZKEWU.

Kohlhoff, KJ; Jahn, TR; Lomas, DA; Dobson, CM; Crowther, DC; Vendruscolo, M; (2011) The iFly tracking system for an automated locomotor and behavioural analysis of Drosophila melanogaster. Integr Biol (Camb) , 3 (7) 755 - 760. 10.1039/c0ib00149j.

Kong, X; Cho, MH; Anderson, W; Coxson, HO; Muller, N; Washko, G; ... ECLIPSE Study NETT Investigators,; + view all (2011) Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Am J Respir Crit Care Med , 183 (1) 43 - 49. 10.1164/rccm.201004-0541OC.

Kotsiou, E; Brzostek, J; Lenart, I; Antoniou, AN; Dyson, J; Gould, KG; (2011) Dimerization of Soluble Disulfide Trap Single-Chain Major Histocompatibility Complex Class I Molecules Dependent on Peptide Binding Affinity. ANTIOXID REDOX SIGN , 15 (3) 635 - 644. 10.1089/ars.2010.3691.

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; ... GCIG,; + view all (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (18)

Kristensen, G; Perren, T; Qian, W; Pfisterer, J; Ledermann, JA; Joly, F; ... GCIG,; + view all (2011) Result of interim analysis of overall survival in the GCIG ICON7 phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Kroemer, G; Adjemian, S; Michaud, M; Martins, I; Kepp, O; Sukkurwala, AQ; ... Zitvogel, L; + view all (2011) [Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]. Bull Mem Acad R Med Belg , 166 (3-4) 130 - 138.

Kudsiova, L; Fridrich, B; Ho, J; Mustapa, MFM; Campbell, F; Welser, K; ... Lawrence, MJ; + view all (2011) Lipopolyplex Ternary Delivery Systems Incorporating C14 Glycerol-Based Lipids. MOL PHARMACEUT , 8 (5) 1831 - 1847. 10.1021/mp2001796.

Kudsiova, L; Ho, J; Fridrich, B; Harvey, R; Keppler, M; Ng, T; ... Lawrence, MJ; + view all (2011) Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection. MOL BIOSYST , 7 (2) 422 - 436. 10.1039/c0mb00149j.

Kulkarni, S; Sitaru, C; Jakus, Z; Anderson, KE; Damoulakis, G; Davidson, K; ... Hawkins, PT; + view all (2011) PI3Kβ plays a critical role in neutrophil activation by immune complexes. Sci Signal , 4 (168) ra23 - ?. 10.1126/scisignal.2001617.

Lafont, E; Kitatani, K; Okazaki, T; Ségui, B; (2011) Regulation of death and growth signals at the plasma membrane by sphingomyelin synthesis: implications for hematological malignancies. Recent Pat Anticancer Drug Discov , 6 (3) 324 - 333.

Lawrenson, K; Sproul, D; Grun, B; Notaridou, M; Benjamin, E; Jacobs, IJ; ... Gayther, SA; + view all (2011) Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. CARCINOGENESIS , 32 (10) 1540 - 1549. 10.1093/carcin/bgr140.

Lawson, AR; Hindley, GF; Forshew, T; Tatevossian, RG; Jamie, GA; Kelly, GP; ... Sheer, D; + view all (2011) RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res , 21 (4) 505 - 514. 10.1101/gr.115782.110.

Ledermann, JA; (2011) Benefits of Enhancing the Platinum-Free Interval in the Treatment of Relapsed Ovarian Cancer More Than Just a Hypothesis? INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 21 S9 - S11. 10.1097/IGC.0b013e318217b30b.

Ledermann, JA; Hackshaw, A; Kaye, S; Jayson, G; Gabra, H; McNeish, I; ... Rustin, G; + view all (2011) Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer. J CLIN ONCOL , 29 (28) 3798 - 3804. 10.1200/JCO.2010.33.5208.

Ledermann, JA; Harter, P; Gourley, C; Friedlander, M; Vergote, IB; Rustin, GJS; ... Matulonis, U; + view all (2011) Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). JOURNAL OF CLINICAL ONCOLOGY , 29 (15)

Ledermann, JA; Marth, C; Carey, MS; Birrer, M; Bowtell, DDL; Kaye, S; ... Gynecologic Canc InterGrp,; + view all (2011) Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer. INT J GYNECOL CANCER , 21 (4) 763 - 770. 10.1097/IGC.0b013e31821b2669.

Ledermann, JA; Raja, FA; (2011) Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer. Eur J Cancer , 47 Suppl 3 S104 - S115. 10.1016/S0959-8049(11)70154-X.

Ledermann, JA; Raja, FA; (2011) Mucinous cancers: Ovary. Rare and Uncommon Gynecological Cancers: A Clinical Guide 67 - 73. 10.1007/978-3-642-13492-0_5.

Lee, AJ; Endesfelder, D; Rowan, AJ; Walther, A; Birkbak, NJ; Futreal, PA; ... Swanton, C; + view all (2011) Chromosomal instability confers intrinsic multidrug resistance. Cancer Res , 71 (5) 1858 - 1870. 10.1158/0008-5472.CAN-10-3604.

Lemech, C; Arkenau, H-T; (2011) Biomarkers in advanced colorectal cancer: Challenges in translating clinical research into practice. Cancers , 3 (2) 1844 - 1860. 10.3390/cancers3021844. Gold open access

Leoni, LM; Hartley, JA; (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. SEMIN HEMATOL , 48 (2) S12 - S23. 10.1053/j.seminhematol.2011.03.003.

Leung, MH; Oriyo, NM; Gillespie, SH; Charalambous, BM; (2011) The adaptive potential during nasopharyngeal colonisation of Streptococcus pneumoniae. Infect Genet Evol , 11 (8) 1989 - 1995. 10.1016/j.meegid.2011.09.002.

Li, Q; Birkbak, NJ; Gyorffy, B; Szallasi, Z; Eklund, AC; (2011) Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics , 12 474 - ?. 10.1186/1471-2105-12-474.

Li, Q; Eklund, AC; Birkbak, NJ; Desmedt, C; Haibe-Kains, B; Sotiriou, C; ... Szallasi, Z; + view all (2011) Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response. BMC Bioinformatics , 12 310 - ?. 10.1186/1471-2105-12-310.

Li, S-C; Chan, W-C; Lai, C-H; Tsai, K-W; Hsu, C-N; Jou, Y-S; ... Lin, W-C; + view all (2011) UMARS: Un-MAppable Reads Solution. BMC Bioinformatics , 12 (Suppl 1) S9 - S9. 10.1186/1471-2105-12-S1-S9. Gold open access

Li, S-C; Liao, Y-L; Chan, W-C; Ho, M-R; Tsai, K-W; Hu, L-Y; ... Lin, W-C; + view all (2011) Interrogation of rabbit miRNAs and their isomiRs. Genomics , 98 (6) 453 - 459. 10.1016/j.ygeno.2011.08.008.

Liccardi, G; Hartley, JA; Hochhauser, D; (2011) EGFR Nuclear Translocation Modulates DNA Repair following Cisplatin and Ionizing Radiation Treatment. CANCER RES , 71 (3) 1103 - 1114. 10.1158/0008-5472.CAN-10-2384. Gold open access

Lindblad-Toh, K; Garber, M; Zuk, O; Lin, MF; Parker, BJ; Washietl, S; ... Kellis, M; + view all (2011) A high-resolution map of human evolutionary constraint using 29 mammals. Nature , 478 (7370) 476 - 482. 10.1038/nature10530.

Linthorst, GE; Germain, DP; Hollak, CEM; Hughes, D; Rolfs, A; Wanner, C; Mehta, A; (2011) Expert opinion on temporary treatment recommendations for Fabry the disease during the shortage of enzyme replacement therapy (ERT). MOL GENET METAB , 102 (1) 99 - 102. 10.1016/j.ymgme.2010.11.155.

Lipman, PJ; Cho, MH; Bakke, P; Gulsvik, A; Kong, X; Lomas, DA; ... Lange, C; + view all (2011) On the follow-up of genome-wide association studies: an overall test for the most promising SNPs. Genet Epidemiol , 35 (5) 303 - 309. 10.1002/gepi.20578.

Liu, B; Moloney, A; Meehan, S; Morris, K; Thomas, SE; Serpell, LC; ... Crowther, DC; + view all (2011) Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem , 286 (6) 4248 - 4256. 10.1074/jbc.M110.158980.

Liu, H; Wang, W; Chew, SK; Lee, SC; Li, J; Vassiliou, GS; ... Liu, P; + view all (2011) Stella-Cre mice are highly efficient Cre deleters. Genesis , 49 (8) 689 - 695. 10.1002/dvg.20741.

Lobo, C; McQueen, A; Beale, T; Kocjan, G; (2011) The UK Royal College of Pathologists thyroid fine-needle aspiration diagnostic classification is a robust tool for the clinical management of abnormal thyroid nodules. Acta Cytol , 55 (6) 499 - 506. 10.1159/000333234.

Locke, DP; Hillier, LW; Warren, WC; Worley, KC; Nazareth, LV; Muzny, DM; ... Wilson, RK; + view all (2011) Comparative and demographic analysis of orang-utan genomes. Nature , 469 (7331) 529 - 533. 10.1038/nature09687.

Lolkema, MP; Arkenau, HT; Harrington, K; Roxburgh, P; Morrison, R; Roulstone, V; ... de Bono, JS; + view all (2011) A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res , 17 (3) 581 - 588. 10.1158/1078-0432.CCR-10-2159.

Lopez, MN; Pesce, B; Kurte, M; Perez, C; Segal, G; Roa, J; ... Salazar-Onfray, F; + view all (2011) A synthetic peptide homologous to IL-10 functional domain induces monocyte differentiation to TGF-beta plus tolerogenic dendritic cells. IMMUNOBIOLOGY , 216 (10) 1117 - 1126. 10.1016/j.imbio.2011.04.006.

Lotta, LA; Wu, HM; Mackie, IJ; Noris, M; Veyradier, A; Machin, SJ; ... Peyvandi, F; + view all (2011) Residual plasmatic activity of ADAMTS13 in congenital thrombotic thrombocytopenic purpura and its correlation with disease phenotype. J THROMB HAEMOST , 9 26 - 27.

Louis, CU; Savoldo, B; Dotti, G; Pule, M; Yvon, E; Myers, GD; ... Brenner, MK; + view all (2011) Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood , 118 (23) 6050 - 6056. 10.1182/blood-2011-05-354449.

Lowry, L; Smith, P; Qian, W; Falk, S; Benstead, K; Illidge, T; ... Hoskin, P; + view all (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol , 100 (1) 86 - 92. 10.1016/j.radonc.2011.05.013.

Mackie, IJ; Langley, K; Chitolie, A; Leisner, R; Scully, M; Machin, S; Peyvandi, F; (2011) Discrepancies between different types of ADAMTS13 assays in patients with thrombotic microangiopathies. J THROMB HAEMOST , 9 210 - 210.

Mackinnon, S; Chakraverty, R; (2011) Families get mobilized to treat AML. BLOOD , 117 (3) 746 - 748. 10.1182/blood-2010-11-315929.

Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; ... Gluud, C; + view all (2011) Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials. Blood Cells Mol Dis , 47 (3) 166 - 175. 10.1016/j.bcmd.2011.07.002.

Mahadevan, D; Plummer, R; Squires, MS; Rensvold, D; Kurtin, S; Pretzinger, C; ... Calvert, H; + view all (2011) A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors. ANN ONCOL , 22 (9) 2137 - 2143. 10.1093/annonc/mdq734.

Manchanda, R; Abdelraheim, A; Johnson, M; Rosenthal, AN; Benjamin, E; Brunell, C; ... Menon, U; + view all (2011) Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG-INT J OBSTET GY , 118 (7) 814 - 824. 10.1111/j.1471-0528.2011.02920.x.

Mansour, MR; Look, AT; (2011) Discovery of a secreted tumor suppressor provides a promising therapeutic strategy for follicular lymphoma. Cancer Cell , 20 (5) 559 - 561. 10.1016/j.ccr.2011.10.027.

Martins, I; Kepp, O; Schlemmer, F; Adjemian, S; Tailler, M; Shen, S; ... Kroemer, G; + view all (2011) Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene , 30 (10) 1147 - 1158. 10.1038/onc.2010.500.

Masir, N; Jones, M; Marafioti, T; Mason, DY; (2011) Heterogeneous expression of B cell-associated markers in follicular lymphoma. Histopathology , 58 (4) 633 - 636. 10.1111/j.1365-2559.2011.03782.x.

Mattar, CNZ; Nathwani, AC; Waddington, SN; Dighe, N; Kaeppel, C; Nowrouzi, A; ... Chan, JKY; + view all (2011) Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques. MOL THER , 19 (11) 1950 - 1960. 10.1038/mt.2011.107.

Mattes, FM; Vargas, A; Kopycinski, J; Hainsworth, EG; Sweny, P; Nebbia, G; ... Emery, VC; + view all (2011) Erratum: Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation (American Journal of Transplantation (2008) 8 (990-999) DOI: 10.1111/j.1600-6143.2008.02191.x). American Journal of Transplantation , 11 (5) 1107 - 1107. 10.1111/j.1600-6143.2011.03549.x.

Maughan, TS; Adams, RA; Smith, CG; Meade, AM; Seymour, MT; Wilson, RH; ... MRC COIN Trial Investigators,; + view all (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet , 377 (9783) 2103 - 2114. 10.1016/S0140-6736(11)60613-2.

Maybin, JA; Battersby, S; Hirani, N; Nikitenko, LL; Critchley, HOD; Jabbour, HN; (2011) The Expression and Regulation of Adrenomedullin in the Human Endometrium: A Candidate for Endometrial Repair. ENDOCRINOLOGY , 152 (7) 2845 - 2856. 10.1210/en.2010-1256.

McDonald, V; Pizzey, A; Machin, SJ; Scully, MA; (2011) The development of acute idiopathic TTP is not associated with changes in T cell or T-regulatory cell numbers. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 915 - 916.

McIntosh, J; Lenting, P; Tuddenham, E; Nawathe, S; Waddington, S; Gray, J; ... Nathwani, A; + view all (2011) AAV mediated Factor VIII expression from a novel expression cassette with a potent codon-optimised FVIII construct. HUMAN GENE THERAPY , 22 (10) A28 - A28.

McIntosh, JH; Cochrane, M; Cobbold, S; Waldmann, H; Nathwani, SA; Davidoff, AM; Nathwani, AC; (2011) Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine. Gene Ther. 10.1038/gt.2011.64.

Melichar, B; Casado, E; Bridgewater, J; Bennouna, J; Campone, M; Vitek, P; ... Tabernero, J; + view all (2011) Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial. Br J Cancer , 105 (11) 1646 - 1653. 10.1038/bjc.2011.438.

Mendoza-Naranjo, A; Bouma, G; Pereda, C; Ramirez, M; Webb, KF; Tittarelli, A; ... Salazar-Onfray, F; + view all (2011) Functional Gap Junctions Accumulate at the Immunological Synapse and Contribute to T Cell Activation. J IMMUNOL , 187 (6) 3121 - 3132. 10.4049/jimmunol.1100378.

Meyer, C; Sevko, A; Ramacher, M; Bazhin, AV; Falk, CS; Osen, W; ... Umansky, V; + view all (2011) Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model. Proc Natl Acad Sci U S A , 108 (41) 17111 - 17116. 10.1073/pnas.1108121108.

Michaud, M; Martins, I; Sukkurwala, AQ; Adjemian, S; Ma, Y; Pellegatti, P; ... Kroemer, G; + view all (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science , 334 (6062) 1573 - 1577. 10.1126/science.1208347.

Mindell, J; Aresu, M; Zaninotto, P; Falaschetti, E; Poulter, N; (2011) Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey-2006. Clinical Endocrinology , 75 (5) 621 - 627. 10.1111/j.1365-2265.2011.04094.x. Green open access

Mingozzi, F; Basner-Tschakarjan, E; Chen, Y; Nathwani, AC; Tuddenham, EGD; Rosales, C; ... High, KA; + view all (2011) Dose-dependent activation of capsid-specific T cells after AAV serotype 8 vector administration in a clinical study for hemophilia B. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 9 761 - 762.

Mitchison, NA; Bhattacharya, S; Tuddenham, EGD; (2011) Human Congenital Diseases with Mixed Modes of Inheritance Have a Shortage of Recessive Disease. A Demographic Scenario? ANN HUM GENET , 75 688 - 693. 10.1111/j.1469-1809.2011.00679.x.

Mohamedbhai, SG; Sibson, K; Marafioti, T; Kayani, I; Lowry, L; Goldstone, AH; ... Ardeshna, KM; + view all (2011) Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index > 95%. BRIT J HAEMATOL , 152 (2) 175 - 181. 10.1111/j.1365-2141.2010.08447.x.

Mohammed, K; Dignan, F; Ethell, ME; Davies, FE; Morgan, GJ; Riley, U; ... Shaw, BE; + view all (2011) An early computed tomography-guided antifungal treatment strategy is safe and efficacious in patients undergoing chemotherapy for high-risk acute leukemia. LEUKEMIA LYMPHOMA , 52 (2) 339 - 340. 10.3109/10428194.2010.527407.

Morris, C; Cook, G; Streetly, M; Kettle, P; Drake, M; Quinn, M; ... Cavenagh, J; + view all (2011) Re-transplantation after bortezomib-based therapy. BRIT J HAEMATOL , 153 (5) 666 - 668. 10.1111/j.1365-2141.2010.08521.x.

Morris, CR; Kim, HY; Trachtenberg, F; Wood, J; Quinn, CT; Sweeters, N; ... Thalassemia Clinical Res Network,; + view all (2011) Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report. BLOOD , 118 (14) 3794 - 3802. 10.1182/blood-2010-11-319152.

Myers, RM; Stamatoyannopoulos, J; Snyder, M; Dunham, I; Hardison, RC; Bernstein, BE; ... Good, PJ; + view all (2011) A user's guide to the Encyclopedia of DNA elements (ENCODE). PLoS Biology , 9 (4) , Article e1001046. 10.1371/journal.pbio.1001046. Green open access

Nathwani, A; Tuddenham, EGD; Rosales, C; Macintosh, J; Chowdary, P; Riddell, A; ... Davidoff, AM; + view all (2011) A Phase I/II clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human FIX for Haemophilia B gene therapy. HUMAN GENE THERAPY , 22 (10) A20 - A20.

Nathwani, AC; Rosales, C; McIntosh, J; Rastegarlari, G; Nathwani, D; Raj, D; ... Davidoff, AM; + view all (2011) Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins. MOL THER , 19 (5) 876 - 885. 10.1038/mt.2010.274.

Nicolaides, TP; Li, H; Solomon, DA; Hariono, S; Hashizume, R; Barkovich, K; ... James, CD; + view all (2011) Targeted therapy for BRAFV600E malignant astrocytoma. Clin Cancer Res , 17 (24) 7595 - 7604. 10.1158/1078-0432.CCR-11-1456.

O'Mahony, C; Coats, C; Cardona, M; Garcia, A; Calcagnino, M; Murphy, E; ... Elliott, PM; + view all (2011) Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease. Europace , 13 (12) 1781 - 1788. 10.1093/europace/eur267.

Osawa, T; Davies, D; Hartley, JA; (2011) Mechanism of cell death resulting from DNA interstrand cross-linking in mammalian cells. CELL DEATH DIS , 2 , Article e187. 10.1038/cddis.2011.70. Gold open access

Pacey, S; Wilson, RH; Walton, M; Eatock, MM; Hardcastle, A; Zetterlund, A; ... Judson, I; + view all (2011) A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin Cancer Res , 17 (6) 1561 - 1570. 10.1158/1078-0432.CCR-10-1927.

Partridge, L; Alic, N; Bjedov, I; Piper, MDW; (2011) Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network. Experimental Gerontology , 46 (5) 376 - 381. 10.1016/j.exger.2010.09.003. Green open access

Patel, B; Dey, A; Ghorani, E; Kumar, S; Malam, Y; Rai, L; ... Fielding, AK; + view all (2011) Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights. MOL THER , 19 (6) 1034 - 1040. 10.1038/mt.2011.44.

Paul, DS; Nisbet, JP; Yang, TP; Meacham, S; Rendon, A; Hautaviita, K; ... Deloukas, P; + view all (2011) Maps of open chromatin guide the functional follow-up of genome-wide association signals: application to hematological traits. PLoS Genet , 7 (6) , Article e1002139. 10.1371/journal.pgen.1002139. Green open access

Payne, EM; Bolli, N; Rhodes, J; Abdel-Wahab, OI; Levine, R; Hedvat, CV; ... Look, AT; + view all (2011) Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood , 118 (4) 903 - 915. 10.1182/blood-2010-11-318022.

Peggs, KS; (2011) Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies. Expert Rev Anticancer Ther , 11 (11) 1667 - 1670. 10.1586/era.11.159.

Peggs, KS; Thomson, K; Samuel, E; Dyer, G; Armoogum, J; Chakraverty, R; ... Lowdell, MW; + view all (2011) Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation. CLIN INFECT DIS , 52 (1) 49 - 57. 10.1093/cid/ciq042.

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; ... Taher, A; + view all (2011) Continued improvement in myocardial T2(star) over two years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload. Haematologica - The Hematology Journal , 96 (1) 48 - 54. 10.3324/haematol.2010.031468. Green open access

Perren, TJ; Swart, AM; Pfisterer, J; Ledermann, JA; Pujade-Lauraine, E; Kristensen, G; ... ICON7 Investigators,; + view all (2011) A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med , 365 (26) 2484 - 2496. 10.1056/NEJMoa1103799.

Petit, SJ; Wise, EL; Chambers, JC; Sehmi, J; Chayen, NE; Kooner, JS; Pease, JE; (2011) The CXCL16 A181V Mutation Selectively Inhibits Monocyte Adhesion to CXCR6 but Is Not Associated With Human Coronary Heart Disease. ARTERIOSCL THROM VAS , 31 (4) 914 - 920. 10.1161/ATVBAHA.110.220558.

Pillay, N; Amary, FM; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 does not regulate brachyury expression in human chordomas and osteosarcomas. Histopathology , 59 (5) 1025 - 1027. 10.1111/j.1365-2559.2011.03973.x.

Plummer, R; Wilson, RH; Calvert, H; Boddy, AV; Griffin, M; Sludden, J; ... Nishiya, T; + view all (2011) A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours. BRIT J CANCER , 104 (4) 593 - 598. 10.1038/bjc.2011.6.

Poiroux, G; Pitié, M; Culerrier, R; Lafont, E; Ségui, B; Van Damme, EJ; ... Benoist, H; + view all (2011) Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy. PLoS One , 6 (8) , Article e23315. 10.1371/journal.pone.0023315. Green open access

Porakishvili, N; Memon, A; Vispute, K; Kulikova, N; Clark, EA; Rai, KR; ... Lydyard, PM; + view all (2011) CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 153 (4) 486 - 498. 10.1111/j.1365-2141.2011.08605.x.

Pors, K; Loadman, PM; Shnyder, SD; Sutherland, M; Sheldrake, HM; Guino, M; ... Patterson, LH; + view all (2011) Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity. CHEM COMMUN , 47 (44) 12062 - 12064. 10.1039/c1cc15638a.

Porter, JB; Evangeli, M; El-Beshlawy, A; (2011) Challenges of adherence and persistence with iron chelation therapy. Int J Hematol , 94 (5) 453 - 460. 10.1007/s12185-011-0927-3.

Porter, JB; Lin, KH; Beris, P; Forni, GL; Taher, A; Habr, D; ... EPIC Study Investigators,; + view all (2011) Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias. EUR J HAEMATOL , 87 (4) 338 - 348. 10.1111/j.1600-0609.2011.01660.x. Gold open access

Presneau, N; Shalaby, A; Ye, H; Pillay, N; Halai, D; Idowu, B; ... Flanagan, AM; + view all (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J Pathol , 223 (3) 327 - 335. 10.1002/path.2816.

Presneau, N; Shalaby, A; Ye, HT; Pillay, N; Halai, D; Idowu, B; ... Flanagan, AM; + view all (2011) Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study. J PATHOL , 223 (3) 327 - 335. 10.1002/path.2816.

Proctor, IE; McNamara, C; Rodriguez-Justo, M; Isaacson, PG; Ramsay, A; (2011) Importance of Expert Central Review in the Diagnosis of Lymphoid Malignancies in a Regional Cancer Network. J CLIN ONCOL , 29 (11) 1431 - 1435. 10.1200/JCO.2010.31.2223.

Puzanov, I; Lee, W; Chen, AP; Calcutt, MW; Hachey, DL; Vermeulen, WL; ... Rothenberg, ML; + view all (2011) Phase I Pharmacokinetic and Pharmacodynamic Study of SJG-136, a Novel DNA Sequence Selective Minor Groove Cross-linking Agent, in Advanced Solid Tumors. CLIN CANCER RES , 17 (11) 3794 - 3802. 10.1158/1078-0432.CCR-10-2056.

Qiu, W; Cho, MH; Riley, JH; Anderson, WH; Singh, D; Bakke, P; ... ECLIPSE Investigators,; + view all (2011) Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One , 6 (9) , Article e24395 . 10.1371/journal.pone.0024395. Green open access

Quezada, SA; Peggs, KS; (2011) Tumor-reactive CD4(+) T cells: plasticity beyond helper and regulatory activities. IMMUNOTHERAPY-UK , 3 (8) 915 - 917. 10.2217/IMT.11.83.

Quezada, SA; Peggs, KS; Simpson, TR; Allison, JP; (2011) Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. IMMUNOL REV , 241 104 - 118. 10.1111/j.1600-065X.2011.01007.x.

Quinn, J; Glassford, J; Percy, L; Munson, P; Marafioti, T; Rodriguez-Justo, M; Yong, K; (2011) APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status. BLOOD , 117 (3) 890 - 901. 10.1182/blood-2010-01-264424.

Raj, D; Davidoff, AM; Nathwani, AC; (2011) Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges. EXPERT REV HEMATOL , 4 (5) 539 - 549. 10.1586/EHM.11.48.

Raja, FA; Griffin, CL; Qian, W; Hirte, H; Parmar, MK; Swart, AM; Ledermann, JA; (2011) Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer. BRIT J CANCER , 105 (7) 884 - 889. 10.1038/bjc.2011.334.

Rajkumar, V; Dearling, JL; Packard, A; Pedley, RB; (2011) Radioimmunotherapy: optimizing delivery to solid tumors. Ther Deliv , 2 (5) 567 - 572.

Rakyan, VK; Beyan, H; Down, TA; Hawa, MI; Maslau, S; Aden, D; ... Leslie, RD; + view all (2011) Identification of Type 1 Diabetes-Associated DNA Methylation Variable Positions That Precede Disease Diagnosis. PLOS GENET , 7 (9) , Article e1002300. 10.1371/journal.pgen.1002300. Green open access

Rakyan, VK; Down, TA; Balding, DJ; Beck, S; (2011) Epigenome-wide association studies for common human diseases. NAT REV GENET , 12 (8) 529 - 541. 10.1038/nrg3000.

Ran, Y; Ethaar, E-E; Vineeth, R; Mathew, R; Barbara, PR; Erik, A; (2011) One-pot Formation of a I-125-labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS , 54 S57 - S57.

Rani, A; Afzali, B; Kelly, A; Tewolde-Berhan, L; Hackett, M; Kanhere, AS; ... John, S; + view all (2011) IL-2 regulates expression of C-MAF in human CD4 T cells. J Immunol , 187 (7) 3721 - 3729. 10.4049/jimmunol.1002354.

Rashid, ST; Yusa, K; Strick-Marchand, H; Lomas, DA; Bradly, A; Vallier, L; (2011) Human induced pluripotent stem cells for cell therapy against Inherited Metabolic disorders. HUMAN GENE THERAPY , 22 (10) A9 - A10.

REA, CJ; FOLEY, JH; INGERSLEV, J; SØRENSEN, B; (2011) Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A. Journal of Thrombosis and Haemostasis , 9 (3) 510 - 516. 10.1111/j.1538-7836.2010.04171.x.

Reid, JM; Buhrow, SA; Kuffel, MJ; Jia, L; Spanswick, VJ; Hartley, JA; ... Ames, MM; + view all (2011) Pharmacokinetics, pharmacodynamics and metabolism of the dimeric pyrrolobenzodiazepine SJG-136 in rats. CANCER CHEMOTH PHARM , 68 (3) 777 - 786. 10.1007/s00280-010-1517-4.

Renfree, MB; Papenfuss, AT; Deakin, JE; Lindsay, J; Heider, T; Belov, K; ... Worley, KC; + view all (2011) Genome sequence of an Australian kangaroo, Macropus eugenii, provides insight into the evolution of mammalian reproduction and development. Genome Biology , 12 (8) R81 - R81. 10.1186/gb-2011-12-8-r81. Green open access

Richardson, SE; McNamara, C; (2011) The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future. Adv Hematol , 2011 865870 - ?. 10.1155/2011/865870.

Ringwald, M; Iyer, V; Mason, JC; Stone, KR; Tadepally, HD; Kadin, JA; ... Skarnes, WC; + view all (2011) The IKMC web portal: a central point of entry to data and resources from the International Knockout Mouse Consortium. NUCLEIC ACIDS RES , 39 D849 - D855. 10.1093/nar/gkq879. Gold open access

Rizza, SA; Challagundla, KB; Natesampillai, S; Bren, GD; Sykora, J; Walczak, H; Badley, AD; (2011) TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes. PLoS ONE , 6 (11) , Article e27171. 10.1371/journal.pone.0027171. Green open access

Robinson, J; Mistry, K; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2011) The IMGT/HLA Database. Nucleic Acids Research , 39 D1171 - D1176.

Roddie, C; Peggs, KS; (2011) Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation. EXPERT OPIN BIOL TH , 11 (4) 473 - 487. 10.1517/14712598.2011.554811.

Rodríguez-González, R; Millán, M; Sobrino, T; Miranda, E; Brea, D; de la Ossa, NP; ... Castillo, J; + view all (2011) The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome. Thromb Haemost , 105 (3) 421 - 429. 10.1160/TH10-09-0621.

Rodríguez-González, R; Sobrino, T; Rodríguez-Yáñez, M; Millán, M; Brea, D; Miranda, E; ... Castillo, J; + view all (2011) Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med , 9 58 - ?. 10.1186/1479-5876-9-58.

Rosales, C; McIntosh, J; Hanley, J; Nathwani, A; Morton, C; Davidoff, A; (2011) A novel epigenetic modifier significantly improves recombinant adeno-associated virus vector mediated transgene expression in mice. HUMAN GENE THERAPY , 22 (10) A107 - A107.

Roylance, R; Endesfelder, D; Gorman, P; Burrell, RA; Sander, J; Tomlinson, I; ... Swanton, C; + view all (2011) Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer. Cancer Epidemiol Biomarkers Prev , 20 (10) 2183 - 2194. 10.1158/1055-9965.EPI-11-0343.

Rustin, G; Reed, N; Jayson, GC; Ledermann, JA; Adams, M; Perren, T; ... Kaye, S; + view all (2011) A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer. ANN ONCOL , 22 (11) 2411 - 2416. 10.1093/annonc/mdq780.

Sabry, M; Tsirogianni, M; Bakhsh, IA; North, J; Sivakumaran, J; Giannopoulos, K; ... Lowdell, MW; + view all (2011) Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors. J Immunol , 187 (12) 6227 - 6234. 10.4049/jimmunol.1101640.

Salazar, R; Plummer, R; Oaknin, A; Robinson, A; Pardo, B; Soto-Matos, A; ... Calvert, AH; + view all (2011) Phase I study of weekly plitidepsin as 1-hour infusion combined with carboplatin in patients with advanced solid tumors or lymphomas. INVEST NEW DRUG , 29 (6) 1406 - 1413. 10.1007/s10637-010-9488-1.

Salomoni, P; (2011) KAPping PML nuclear body number. CELL CYCLE , 10 (5) 735 - 736. 10.4161/cc.10.5.14927.

Salomoni, P; Betts-Henderson, J; (2011) The Role of PML in the Nervous System. MOL NEUROBIOL , 43 (2) 114 - 123. 10.1007/s12035-010-8156-y.

Saravanan, K; Barlow, HC; Barton, M; Calvert, AH; Golding, BT; Newell, DR; ... Griffin, RJ; + view all (2011) Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein. J MED CHEM , 54 (6) 1847 - 1859. 10.1021/jm101493z.

Scaffidi, P; Misteli, T; (2011) In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol , 13 (9) 1051 - 1061. 10.1038/ncb2308.

Screaton, NJ; Miller, FN; Patel, BD; Groves, A; Tasker, AD; Lomas, DA; Flower, CD; (2011) The clinical impact of high resolution computed tomography in patients with respiratory disease. Eur Radiol , 21 (2) 225 - 231. 10.1007/s00330-010-1923-3.

Serrano, AE; Menares-Castillo, E; Garrido-Tapia, M; Ribeiro, CH; Hernandez, CJ; Mendoza-Naranjo, A; ... Molina, MC; + view all (2011) Interleukin 10 decreases MICA expression on melanoma cell surface. IMMUNOL CELL BIOL , 89 (3) 447 - 457. 10.1038/icb.2010.100.

Shah, K; Coats, C; O'Mahony, C; Cardona, M; Garcia, A; Murphy, E; ... Elliott, PM; + view all (2011) Exercise capacity predicts prognosis in anderson fabry disease. EUROPEAN HEART JOURNAL , 32 273 - 273.

Shalaby, A; Presneau, N; Ye, H; Halai, D; Berisha, F; Idowu, B; ... Flanagan, AM; + view all (2011) The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol , 223 (3) 336 - 346. 10.1002/path.2818.

Shaw, BE; Apperley, JF; Russell, NH; Craddock, C; Liakopoulou, E; Potter, MN; ... Byrne, JL; + view all (2011) Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. BRIT J HAEMATOL , 153 (2) 244 - 252. 10.1111/j.1365-2141.2011.08615.x.

Shaw, BE; Confer, DL; Hwang, WY; Pamphilon, DH; Pulsipher, MA; (2011) Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association. HAEMATOL-HEMATOL J , 96 (7) 942 - 947. 10.3324/haematol.2011.045740. Gold open access

Shimazu, S; Nagamura, Y; Yaguchi, H; Ohkura, N; Tsukada, T; (2011) Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms. Cancer Sci , 102 (11) 2097 - 2102. 10.1111/j.1349-7006.2011.02055.x.

Siddiqui, GK; Maclean, AB; Elmasry, K; Fong, AWT; Morris, RW; Rashid, M; ... Boxer, GM; + view all (2011) Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer. ANGIOGENESIS , 14 (2) 155 - 161. 10.1007/s10456-010-9199-4.

Siddle, HV; Deakin, JE; Coggill, P; Whilming, L; Harrow, J; Kaufman, J; ... Belov, K; + view all (2011) The tammar wallaby major histocompatibility complex shows evidence of past genomic instability. BMC GENOMICS , 12 , Article 421. 10.1186/1471-2164-12-421. Green open access

Siedlinski, M; Cho, MH; Bakke, P; Gulsvik, A; Lomas, DA; Anderson, W; ... ECLIPSE Investigators,; + view all (2011) Genome-wide association study of smoking behaviours in patients with COPD. Thorax , 66 (10) 894 - 902. 10.1136/thoraxjnl-2011-200154.

Silverman, EK; Vestbo, J; Agusti, A; Anderson, W; Bakke, PS; Barnes, KC; ... Crapo, JD; + view all (2011) Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD , 8 (2) 121 - 135. 10.3109/15412555.2011.558864.

Sims, D; Mendes-Pereira, AM; Frankum, J; Burgess, D; Cerone, MA; Lombardelli, C; ... Lord, CJ; + view all (2011) High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing. Genome Biol , 12 (10) R104 - ?. 10.1186/gb-2011-12-10-r104.

Sin, DD; Miller, BE; Duvoix, A; Man, SF; Zhang, X; Silverman, EK; ... ECLIPSE Investigators,; + view all (2011) Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med , 183 (9) 1187 - 1192. 10.1164/rccm.201008-1220OC.

Sivabalasingham, S; Fersht, N; D'Souza, D; Rosenberg, I; Stacey, C; Davies, P; ... Short, S; + view all (2011) Preliminary Results from a Phase I/II Study of Intensity Modulated Radiotherapy in the Treatment of Meningiomas. CLIN ONCOL-UK , 23 (3) S53 - S53.

Smith, SW; Eardley, KS; Croft, AP; Nwosu, J; Howie, AJ; Cockwell, P; ... Savage, CO; + view all (2011) CD248+ stromal cells are associated with progressive chronic kidney disease. Kidney Int , 80 (2) 199 - 207. 10.1038/ki.2011.103.

Sobota, A; Yamashita, R; Xu, Y; Trachtenberg, F; Kohlbry, P; Kleinert, DA; ... Thalassemia Clinical Res Network,; + view all (2011) Quality of life in Thalassemia: A comparison of SF-36 results from the Thalassemia longitudinal cohort to reported literature and the US norms. AM J HEMATOL , 86 (1) 92 - 95. 10.1002/ajh.21896.

Sofueva, S; Osman, F; Lorenz, A; Steinacher, R; Castagnetti, S; Ledesma, J; Whitby, MC; (2011) Ultrafine anaphase bridges, broken DNA and illegitimate recombination induced by a replication fork barrier. Nucleic Acids Research , 39 (15) 6568- 6584. 10.1093/nar/gkr340. Green open access

Sologuren, I; Boisson-Dupuis, S; Pestano, J; Vincent, QB; Fernández-Pérez, L; Chapgier, A; ... Rodríguez-Gallego, C; + view all (2011) Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet , 20 (8) 1509 - 1523. 10.1093/hmg/ddr029.

Spencer, J; Amin, J; Coxhead, P; McGeehan, J; Richards, CJ; Tizzard, GJ; ... Guille, M; + view all (2011) Size Does Matter. Sterically Demanding Metallocene-Substituted 3-Methylidene-Oxindoles Exhibit Poor Kinase Inhibitory Action. ORGANOMETALLICS , 30 (11) 3177 - 3181. 10.1021/om200278j.

Starke, RD; Ferraro, F; Paschalaki, KE; Dryden, NH; McKinnon, TAJ; Sutton, RE; ... Randi, AM; + view all (2011) Endothelial von Willebrand factor regulates angiogenesis. BLOOD , 117 (3) 1071 - 1080. 10.1182/blood-2010-01-264507.

Starke, RD; Paschalaki, KE; Ferraro, F; Dryden, NH; McKinnon, TAJ; Sutton, RE; ... Randi, AM; + view all (2011) BLOOD-DERIVED ENDOTHELIAL PROGENITOR CELLS FROM VON WILLEBRAND'S DISEASE PATIENTS DEMONSTRATE THAT VON WILLEBRAND FACTOR REGULATES ANGIOGENESIS. HEART , 97 (20) 14 - 14. 10.1136/heartjnl-2011-300920b.39.

Stephens, PJ; Greenman, CD; Fu, BY; Yang, FT; Bignell, GR; Mudie, LJ; ... Campbell, PJ; + view all (2011) Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development. CELL , 144 (1) 27 - 40. 10.1016/j.cell.2010.11.055.

Strenger, V; Pfurtscheller, K; Wendelin, G; Aberle, SW; Nacheva, EP; Zohrer, B; ... Popow-Kraupp, T; + view all (2011) Differentiating Inherited Human Herpesvirus Type 6 Genome from Primary Human Herpesvirus Type 6 Infection by Means of Dried Blood Spot from the Newborn Screening Card. J PEDIATR-US , 159 (5) 859 - 861. 10.1016/j.jpeds.2011.06.032.

Strenger, V; Urban, C; Schwinger, W; Nacheva, EP; Aberle, SW; (2011) Transmission of Chromosomally Integrated HHV-6 by Bone Marrow Transplantation. PEDIATR BLOOD CANCER , 56 (1) 171 - 171. 10.1002/pbc.22828.

Stuart, GC; Kitchener, H; Bacon, M; duBois, A; Friedlander, M; Ledermann, J; ... Gynecologic Cancer Intergroup,; + view all (2011) 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int J Gynecol Cancer , 21 (4) 750 - 755. 10.1097/IGC.0b013e31821b2568.

Sun, Y; Hu, J; Zhou, L; Pollard, SM; Smith, A; (2011) Interplay between FGF2 and BMP controls the self-renewal, dormancy and differentiation of rat neural stem cells. J Cell Sci , 124 (Pt 11) 1867 - 1877. 10.1242/jcs.085506.

Surinova, S; Schiess, R; Hüttenhain, R; Cerciello, F; Wollscheid, B; Aebersold, R; (2011) On the development of plasma protein biomarkers. J Proteome Res , 10 (1) 5 - 16. 10.1021/pr1008515.

Svobodová, S; Browning, J; MacGregor, D; Pollara, G; Scolyer, RA; Murali, R; ... Cebon, JS; + view all (2011) Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate. Eur J Cancer , 47 (3) 460 - 469. 10.1016/j.ejca.2010.09.042.

Swerdlow, AJ; Higgins, CD; Smith, P; Cunningham, D; Hancock, BW; Horwich, A; ... Linch, DC; + view all (2011) Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study. J CLIN ONCOL , 29 (31) 4096 - 4104. 10.1200/JCO.2011.34.8268.

Taner, SB; Pando, MJ; Roberts, A; Schellekens, J; Marsh, SG; Malmberg, KJ; ... Brodsky, FM; + view all (2011) Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention. J Immunol , 186 (1) 62 - 72. 10.4049/jimmunol.0903657.

Tat, PA; Sumer, H; Pralong, D; Verma, PJ; (2011) The Efficiency of Cell Fusion-Based Reprogramming Is Affected by the Somatic Cell Type and the Age of Somatic Cells. Cellular Reprogramming (Formerly "Cloning and Stem Cells") , 13 (4) 331 - 344. 10.1089/cell.2011.0002.

Taveirne, S; De Colvenaer, V; Van Den Broeck, T; Van Ammel, E; Bennett, CL; Taghon, T; ... Leclercq, G; + view all (2011) Langerhans cells are not required for epidermal V gamma 3 T cell homeostasis and function. J LEUKOCYTE BIOL , 90 (1) 61 - 68. 10.1189/jlb.1010581.

Taylor, RM; Grieve, A; Gibson, F; Dhawan, A; Franck, LS; (2011) Parental assessment of adolescent quality of life: can it replace self-assessment? Qual Life Res , 20 (10) 1715 - 1720. 10.1007/s11136-011-9904-9.

Thephinlap, C; Phisalaphong, C; Lailerd, N; Chattipakorn, N; Winichagoon, P; Vadolus, J; ... Srichairatanakool, S; + view all (2011) Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids. MED CHEM , 7 (1) 62 - 69.

Thirlwell, C; Schulz, L; Dibra, H; Beck, S; (2011) Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy. Clin Epigenetics , 3 9 - ?. 10.1186/1868-7083-3-9.

Thomas, MR; Machin, SJ; Mackie, I; Scully, MA; (2011) B cell activating factor is elevated in acute idiopathic thrombotic thrombocytopenic purpura. Br J Haematol , 155 (5) 620 - 622. 10.1111/j.1365-2141.2011.08730.x.

Thomson, KJ; Mackinnon, S; (2011) T-Cell-Depleted Reduced-Intensity Conditioning Transplantation for Lymphoma: Do Donor Lymphocyte Infusions Really Matter? Reply. J CLIN ONCOL , 29 (9) E244 - E244. 10.1200/JCO.2010.33.1207.

Trachtenberg, F; Vichinsky, E; Haines, D; Pakbaz, Z; Mednick, L; Sobota, A; ... Thalassemia Clinical Res Network,; + view all (2011) Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia. AM J HEMATOL , 86 (5) 433 - 436. 10.1002/ajh.21993.

Tsai, K-W; Liao, Y-L; Wu, C-W; Hu, L-Y; Li, S-C; Chan, W-C; ... Lin, W-C; + view all (2011) Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics , 6 (10) 1189 - 1197. 10.4161/epi.6.10.16535.

Tsai, K-W; Wu, C-W; Hu, L-Y; Li, S-C; Liao, Y-L; Lai, C-H; ... Lin, W-C; + view all (2011) Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. International Journal of Cancer , 129 (11) 2600 - 2610. 10.1002/ijc.25919.

Tsui, NBY; Kadir, RA; Chan, KCA; Chi, C; Mellars, G; Tuddenham, EG; ... Lo, YMD; + view all (2011) Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood , 117 (13) 3684 - 3691. 10.1182/blood-2010-10-310789.

van Zyl-Smit, RN; Binder, A; Meldau, R; Mishra, H; Semple, PL; Theron, G; ... Dheda, K; + view all (2011) Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Mycobacterial Burden. PLOS ONE , 6 (12) , Article e28815. 10.1371/journal.pone.0028815. Green open access

Vaughan, S; Coward, JI; Bast, RC; Berchuck, A; Berek, JS; Brenton, JD; ... Balkwill, FR; + view all (2011) Rethinking ovarian cancer: recommendations for improving outcomes. NAT REV CANCER , 11 (10) 719 - 725. 10.1038/nrc3144.

Vazquez, I; Bridgewater, J; (2011) Nonsurgical therapy of biliary tract cancer. Curr Opin Gastroenterol , 27 (3) 258 - 261. 10.1097/MOG.0b013e3283454f09.

Velica, P; Bunce, CM; (2011) A QUICK, SIMPLE AND UNBIASED METHOD TO QUANTIFY C2C12 MYOGENIC DIFFERENTIATION. MUSCLE NERVE , 44 (3) 366 - 370. 10.1002/mus.22056.

Vestbo, J; Edwards, LD; Scanlon, PD; Yates, JC; Agusti, A; Bakke, P; ... ECLIPSE Investigators,; + view all (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med , 365 (13) 1184 - 1192. 10.1056/NEJMoa1105482.

Vichinsky, E; Bernaudin, F; Forni, GL; Gardner, R; Hassell, K; Heeney, MM; ... Coates, T; + view all (2011) Long-term safety and efficacy of deferasirox (Exjade (R)) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease. BRIT J HAEMATOL , 154 (3) 387 - 397. 10.1111/j.1365-2141.2011.08720.x.

Vichinsky, EP; Ohene-Frempong, K; Thein, SL; Lobo, CLD; Inati, A; Thompson, AA; ... Marks, PW; + view all (2011) Transfusion and Chelation Practices in Sickle Cell Disease: A Regional Perspective. PEDIATR HEMAT ONCOL , 28 (2) 124 - 133. 10.3109/08880018.2010.505506.

Vilella, AJ; Birney, E; Flicek, P; Herrero, J; (2011) Considerations for the inclusion of 2x mammalian genomes in phylogenetic analyses. Genome Biology , 12 , Article 401. 10.1186/gb-2011-12-2-401. Green open access

Virgili, A; Koptyra, M; Dasgupta, Y; Glodkowska-Mrowka, E; Stoklosa, T; Nacheva, EP; Skorski, T; (2011) Imatinib Sensitivity in BCR-ABL1-Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele. CANCER RES , 71 (16) 5381 - 5386. 10.1158/0008-5472.CAN-11-0068.

Visone, R; Veronese, A; Rassenti, LZ; Balatti, V; Pearl, DK; Acunzo, M; ... Croce, CM; + view all (2011) miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. BLOOD , 118 (11) 3072 - 3079. 10.1182/blood-2011-01-333484.

Wan, ES; Cho, MH; Boutaoui, N; Klanderman, BJ; Sylvia, JS; Ziniti, JP; ... COPD Gene investigators,; + view all (2011) Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol , 45 (2) 304 - 310. 10.1165/rcmb.2010-0294OC.

Wan, SG; Taccioli, C; Jiang, YB; Chen, HP; Smalley, KJ; Huang, K; ... Fong, LYY; + view all (2011) Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. INT J CANCER , 129 (2) 331 - 345. 10.1002/ijc.25688.

Wang, AT; Sengerova, B; Cattell, E; Inagawa, T; Hartley, JM; Kiakos, K; ... McHugh, PJ; + view all (2011) Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair. GENE DEV , 25 (17) 1859 - 1870. 10.1101/gad.15699211.

Wang, D; Liu, F; Wang, L; Huang, S; Yu, J; (2011) Nonsynonymous substitution rate (Ka) is a relatively consistent parameter for defining fast-evolving and slow-evolving protein-coding genes. Biol Direct , 6 13 - ?. 10.1186/1745-6150-6-13.

Wang, D; Yu, J; (2011) Both size and GC-content of minimal introns are selected in human populations. PLoS One , 6 (3) e17945 - ?. 10.1371/journal.pone.0017945.

Ward, NJ; Buckley, SMK; Waddington, SN; VandenDriessche, T; Chuah, MKL; Nathwani, AC; ... McVey, JH; + view all (2011) Codon optimization of human factor VIII cDNAs leads to high-level expression. BLOOD , 117 (3) 798 - 807. 10.1182/blood-2010-05-282707.

Wen, PJ; Osborne, SL; Zanin, M; Low, PC; Wang, HT; Schoenwaelder, SM; ... Meunier, FA; + view all (2011) Phosphatidylinositol(4,5)bisphosphate coordinates actin-mediated mobilization and translocation of secretory vesicles to the plasma membrane of chromaffin cells. Nat Commun , 2 491 - ?. 10.1038/ncomms1500.

Westbury, CB; Sahlberg, KK; Borresen-Dale, AL; Isacke, CM; Yarnold, JR; (2011) Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. RADIAT ONCOL , 6 , Article 42. 10.1186/1748-717X-6-42. Gold open access

Westin, J; Hellstrand, K; Dhillon, AP; Lagging, M; DITTO-HCV Study Grp,; (2011) Are FoxP3+cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C? J VIRAL HEPATITIS , 18 (2) 149 - 151. 10.1111/j.1365-2893.2010.01277.x.

Whelan, JS; Gelderblom, AH; Jinks, R; Sydes, M; Bramwell, VH; van Glabbeke, M; ... Taminiau, AHM; + view all (2011) Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup randomised controlled trials. Eur J Cancer (47) 895 - 902.

Whelan, JS; Jinks, RC; McTiernan, A; Sydes, MR; Hook, JM; Trani, L; ... Gelderblom, H; + view all (2011) Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials. Ann Oncol 10.1093/annonc/mdr491.

Whelan, JS; Miller, R; (2011) Lung carcinoma with hypertropic osteoarthropathy in a teenager. Rare Tumours , 3:e8

Whiteford, JR; Xian, X; Chaussade, C; Vanhaesebroeck, B; Nourshargh, S; Couchman, JR; (2011) Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell , 22 (19) 3609 - 3624. 10.1091/mbc.E11-02-0099.

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets. BRIT J HAEMATOL , 153 (5) 545 - 556. 10.1111/j.1365-2141.2011.08676.x.

Wickremasinghe, RG; Prentice, AG; Steele, AJ; (2011) p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies. LEUKEMIA , 25 (9) 1400 - 1407. 10.1038/leu.2011.103.

Wilkerson, PM; Dedes, KJ; Wetterskog, D; Mackay, A; Lambros, MB; Mansour, M; ... Reis-Filho, JS; + view all (2011) Functional characterization of EMSY gene amplification in human cancers. J Pathol , 225 (1) 29 - 42. 10.1002/path.2944.


Wykosky, J; Fenton, T; Furnari, F; Cavenee, WK; (2011) Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chin J Cancer , 30 (1) 5 - 12. Gold open access

Yogev, O; Lagos, D; (2011) Noncoding RNAs and cancer. Silence , 2 (1) 6 - ?. 10.1186/1758-907X-2-6. Gold open access

Yogev, O; Naamati, A; Pines, O; (2011) Fumarase: a paradigm of dual targeting and dual localized functions. FEBS J , 278 (22) 4230 - 4242. 10.1111/j.1742-4658.2011.08359.x.

Yogev, O; Pines, O; (2011) Dual targeting of mitochondrial proteins: Mechanism, regulation and function. BBA-BIOMEMBRANES , 1808 (3) 1012 - 1020. 10.1016/j.bbamem.2010.07.004.

Yong, MY; Gonzalez-Beltran, A; Begent, R; (2011) Establishing a knowledge trail from molecular experiments to clinical trials. NEW BIOTECHNOL , 28 (5) 464 - 480. 10.1016/j.nbt.2011.03.016.

Yusa, K; Rashid, ST; Strick-Marchand, H; Varela, I; Liu, PQ; Paschon, DE; ... Vallier, L; + view all (2011) Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature , 478 (7369) 391 - 394. 10.1038/nature10424.

Zhang, EZ; Povazay, B; Laufer, J; Alex, A; Hofer, B; Pedley, B; ... Drexler, W; + view all (2011) Multimodal photoacoustic and optical coherence tomography scanner using an all optical detection scheme for 3D morphological skin imaging. Biomed Opt Express , 2 (8) 2202 - 2215. 10.1364/BOE.2.002202.

Zhang, Q; Wang, H; Kantekure, K; Paterson, JC; Liu, X; Schaffer, A; ... Wasik, MA; + view all (2011) Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. Blood , 118 (11) 3062 - 3071. 10.1182/blood-2011-01-332916.

Zhao, Y-H; Wang, D-P; Zhang, L-L; Zhang, F; Wang, D-M; Zhang, W-Y; (2011) Genomic expression profiles of blood and placenta reveal significant immune-related pathways and categories in Chinese women with gestational diabetes mellitus. Diabetic Medicine , 28 (2) 237 - 246. 10.1111/j.1464-5491.2010.03140.x.

Zhou, YP; Adolfs, Y; Pijnappel, WWMP; Fuller, SJ; Van der Schors, RC; Li, KW; ... Pasterkamp, RJ; + view all (2011) MICAL-1 Is a Negative Regulator of MST-NDR Kinase Signaling and Apoptosis. MOL CELL BIOL , 31 (17) 3603 - 3615. 10.1128/MCB.01389-10.



Zweifel, M; Jayson, GC; Reed, NS; Osborne, R; Hassan, B; Ledermann, J; ... Rustin, GJS; + view all (2011) Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer. ANN ONCOL , 22 (9) 2036 - 2041. 10.1093/annonc/mdq708.


Chapgier, A; (2011) Human Stat1 Deficiencies. LAP Lambert Academic Publishing

JD, O; Adcock, DM; Ambrose Bush, T; de Moerloose, P; Gardiner, C; Ginyard, M; ... others,; + view all (2011) Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Clinical and Laboratory Standards Institute

Book chapter

Lemech, CR; Kristeleit, RS; Arkenau, HT; (2011) Novel Oncology Drug Development Strategies in the Era of Personalised Medicine. In: Kapetanovic, IM, (ed.) Drug Discovery and Development - Present and Future.

Proceedings paper

Albanyan, AA; Albanyan, A; Curry, B; Dragovic, R; Gardiner, C; Biggerstaff, J; ... Harrison, P; + view all (2011) Measurement of procoagulant microvesicles generated within ageing platelet concentrates. In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. (pp. 62 - 63).

Ayto, RM; Reed, M; Baker, R; Steele, AJ; Wickremasinghe, RG; Mehta, AB; Hughes, DA; (2011) Gaucher derived mono-layers prime myeloma cells for survival against chemo-therapeutic agents. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 16 - 16).

Babu, B; Ramos, J; Liu, Y; Chavda, S; Tzou, S; Brockway, O; ... Lee, M; + view all (2011) Design, synthesis, and DNA binding selectivity and affinity studies of the tetraamide PhIPI and its diamino analog PhIP*I. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Bjedov, I; Partridge, L; (2011) A longer and healthier life with TOR down-regulation: genetics and drugs. In: BIOCHEMICAL SOCIETY TRANSACTIONS. (pp. 460 - 465). PORTLAND PRESS LTD

Calvert, AH; (2011) Synthetic lethality in cancer treatment: Current status of PARP inhibitors. In: ANNALS OF ONCOLOGY. (pp. 13 - 13). OXFORD UNIV PRESS

Chavda, S; Liu, Y; Babu, B; Davis, R; Sielaff, A; Ruprich, J; ... Lee, M; + view all (2011) Hx, a novel fluorescent, minor groove and sequence specific recognition element: Design, synthesis, and DNA binding properties of p-anisylbenzimidazole imidazole/pyrrole-containing polyamides. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.

Cook, G; Kirkland, K; Lee, J; Pearce, RM; Apperley, JF; Clark, RE; ... Marks, DI; + view all (2011) Allogeneic Stem Cell Transplantation Induces Long Term Survival in Pateitns with Advanced Chronic Myeloid Leukaemia: A Study of the British Society for Blood and Marrow Transplantation. In: BLOOD. (pp. 1764 - 1764).

Danovi, D; Folarin, A; Pollard, S; (2011) Live Image Based Screen on Glioblastoma Stem Cells. In: EUROPEAN JOURNAL OF CANCER. (pp. S171 - S171). ELSEVIER SCI LTD

Dudderidge, J; Vasdev, N; Wollenschlaeger, A; Okoturo, O; Kelly, J; Stoeber, K; (2011) Diagnosis of bladder cancer by combined detection of minichromosome maintenance 5 protein and NMP22 in urine. In: BJU INTERNATIONAL. (pp. 7 - 7). WILEY-BLACKWELL

Dudderidge, TJ; Beatty, J; Larkin, J; Gore, M; Christmas, TJ; (2011) Surgery for loco-regional recurrence after nephrectomy for renal cell carcinoma (RCC): outcomes after initial incomplete resection and implantational recurrences. In: BJU INTERNATIONAL. (pp. 42 - 42). WILEY-BLACKWELL

Dudderidge, TJ; Robertson, N; Lavan, L; Rashid, T; Hawizy, A; Ogden, CW; (2011) Robotic prostatectomy delivers excellent outcomes and short hospital stay. Access in the NHS should be expanded not limited due to consumable costs. In: BJU INTERNATIONAL. (pp. 34 - 35). WILEY-BLACKWELL

Enver, T; (2011) Gene Regulatory Networks Governing Hematopoietic Stem Cell Development and Identity. In: BLOOD. (pp. 1815 - 1815).

Farren, TW; Liu, F; Macey, MG; Jenner, M; Prentice, A; Nathwani, A; Agrawal, SG; (2011) CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 72 - 72).

Flutter, B; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced Co-Stimulation and Co-Inhibitory Blockade Synergize to Enhance the Functions of Exhausted CTL. In: BLOOD. (pp. 833 - 834).

Flutter, BR; Edwards, N; Zhang, L; Sivakumaran, S; Croft, M; Sykes, M; Chakraverty, R; (2011) Enforced co-stimulation and co-inhibitory blockade synergise to enhance the functions of exhausted CTL. In: IMMUNOLOGY. (pp. 38 - 38).

Galavotti, S; Shaked-Rabi, M; Tulchinsky, E; Brandner, S; Jones, C; Salomoni, P; (2011) THE METABOLIC AUTOPHAGY PATHWAY REGULATES MIGRATION AND INVASION IN GLIOMA. In: NEURO-ONCOLOGY. (pp. 10 - 10). OXFORD UNIV PRESS INC

Gardiner, C; Tannetta, DS; Harrison, P; Redman, CWG; Sargent, IL; (2011) Increased levels of tissue factor activity on syncytiotrophoblast microvesicles released into the maternal circulation during pre-eclampsia. In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. (pp. 169 - 169).

Hagerstrom, MN; Rorby, E; May, G; Tipping, A; Brown, J; Karlsson, G; ... Karlsson, S; + view all (2011) Gata2 Is a Direct Target for Smad-Mediated TGF beta Signaling in Hematopoietic Stem/Progenitor Cells. In: BLOOD. (pp. 580 - 580).

Hartig, N; Munoz-Alegre, M; Young, L; Rodriguez-Viciana, P; (2011) Role of R-Ras GTPases in the Wnt-Planar Cell Polarity pathway. In: MOLECULAR BIOLOGY OF THE CELL.


Hillmen, P; Gribben, JG; Follows, GA; Milligan, D; Sayala, HA; Moreton, P; ... Sub-Grp, NCRICLL; + view all (2011) Final response assessment of the CLL208 trial: an open-label phase II study to investigate the safety and efficacy of rituximab plus chlorambucil in previously untreated patients with CD20-positive B-cell chronic lymphocytic leukaemia (CLL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 21 - 21).


Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Kassen, D; Thrasher, AJ; ... Yong, K; + view all (2011) CD26 Inhibition Can Aid the Homing of Cytokine Activated Mobilized Peripheral Blood (MPB)CD34+Cells to the Bone Marrow (BM) but a Ligand Dependent Attachment Defect Prevents Their Long Term Retention and Subsequent Engraftment. In: BLOOD. (pp. 68 - 68).

Kanga, U; McWhinnie, A; Mourya, MK; Sharma, R; Shaw, BE; Madrigal, A; Mehra, NK; (2011) HLA-DPB1 POLYMORPHISM IN NORTH INDIAN POPULATION. In: HUMAN IMMUNOLOGY. (pp. S137 - S137). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, P; Yong, K; (2011) Deregulation of the bone marrow stromal compartment occurs early in multiple myeloma and precedes osteolytic bone disease. In: BONE. (pp. S253 - S254). ELSEVIER SCIENCE INC

Kassen, D; Rabin, N; Lath, D; Croucher, PI; Yong, K; (2011) Mechanisms of osteoblast supression in multiple myeolma. In: BONE. (pp. S37 - S37). ELSEVIER SCIENCE INC

Kottaridis, P; Tsirogianni, M; North, J; Marden, C; Mackinnon, S; Lowdell, MW; (2011) Results of a Phase 1 Clinical Trial of Allogeneic Tumor-Primed Natural Killer Cells in AML. In: BLOOD. (pp. 431 - 431).

Kuter, DJ; Mehta, A; Hollak, C; Giraldo, P; Hughes, D; Belmatoug, N; ... Zimran, A; + view all (2011) Miglustat Therapy in Type 1 Gaucher Disease: Long-Term Treatment Experience From a Multicenter, Retrospective Cohort Study. In: BLOOD. (pp. 1385 - 1385).

Lee, JW; Yoon, S-S; Shen, ZX; Ganser, A; Hsu, H-C; El-Ali, A; ... Investigators, EPICS; + view all (2011) Hematologic Responses in Patients with Aplastic Anemia Treated with Deferasirox: A Post-Hoc Analysis From the EPIC Study. In: BLOOD. (pp. 591 - 592).

Lotta, LA; Wu, HM; Scully, MA; Noris, M; Veyradier, A; Mackie, IJ; ... Peyvandi, F; + view all (2011) Residual Plasmatic Activity of ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura Correlates with Disease Phenotype. In: BLOOD. (pp. 966 - 966).

Luc, S; Macaulay, IC; Buza-Vidas, N; Bouriez-Jones, T; Lutteropp, M; Woll, P; ... Jacobsen, SEW; + view all (2011) The Earliest Thymic T Cell Progenitors Sustain B Cell and Myeloid Lineage Potentials. In: BLOOD. (pp. 1011 - 1011).

Maramba, A; North, J; Lowdell, MW; Donaldson, C; (2011) IgM ligation triggers Zeta associated protein of 70 kDa (ZAP-70) tyrosine 292 and 319 phosphorylation in B-Chronic lymphocytic leukaemia (B-CLL). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 72 - 73).

McDonald, V; Machin, SJ; Mackie, IJ; Scully, MA; (2011) The Prognostic Effects of Anti-ADAMTS13 IgG, IgA and IgM Antibody Subclasses In Acute Idiopathic TTP and the Effect of Rituximab. In: BLOOD. (pp. 1421 - 1421).


Morris, H; Morgan, MD; Woods, A; Ekeowa, UI; Butherus, K; Holle, JU; ... Harper, L; + view all (2011) ANCA-AAV, polymers and carriage of the Z allele of alpha 1AT. In: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. (pp. 75 - 76).

Nathwani, AC; Tuddenham, EGD; Rosales, C; Macintosh, J; Chowdary, P; Riddell, A; ... Davidoff, AM; + view all (2011) A phase i/ii clinical trial entailing peripheral vein administration of a novel self complementary adeno-associated viral vector encoding human fix for haemophilia b gene therapy. In: HUMAN GENE THERAPY. (pp. A7 - A8). MARY ANN LIEBERT INC

Neufeld, EJ; Galanello, R; Viprakasit, V; Aydinok, Y; Piga, A; Harmatz, P; ... Jr, RHY; + view all (2011) Safety, Tolerability and Dose Response of FBS0701, a Novel Iron Chelator for Treatment of Transfusional Iron Overload: Results of a 24-Week Multicenter, International Phase 2 Study. In: BLOOD. (pp. 315 - 316).

Peggs, K; (2011) The role of alemtuzumab in allogeneic stem cell transplantation. In: IMMUNOLOGY. (pp. 19 - 19).

Perera, G; Ainali, C; Barinaga, G; Williams, A; Mirza, M; Kassen, D; ... Nestle, F; + view all (2011) Systems analysis of psoriasis reveals a dominant IL-22 signature and IL-22 as non redundant checkpoint in psoriatic inflammation. In: JOURNAL OF INVESTIGATIVE DERMATOLOGY. (pp. S89 - S89). NATURE PUBLISHING GROUP

Perera, GK; Williams, A; Barinaga, G; Kassen, D; Barker, J; Ouyang, W; Nestle, FO; (2011) IL-22 is a potential therapeutic target in psoriasis. In: BRITISH JOURNAL OF DERMATOLOGY. (pp. 905 - 906). WILEY-BLACKWELL

Pfeifer, H; Cazzaniga, G; Spinelli, O; Cayuela, J-M; Cave, H; Vandenberghe, P; ... Ottmann, OG; + view all (2011) International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia. In: BLOOD. (pp. 1087 - 1087).

Pillay, N; Fernanda, MF; Berisha, F; Tirabosco, R; Flanagan, AM; (2011) P63 Does Not Regulate Brachyury in Chordomas and Osteosarcomas. In: JOURNAL OF PATHOLOGY. (pp. S24 - S24). WILEY-BLACKWELL

Popat, R; Dickson, J; Khan, I; Cheesman, S; Percy, L; Moore, S; ... Yong, K; + view all (2011) An Alternate Day Dosing Strategy for Lenalidomide in Multiple Myeloma Improves Cost-Effectiveness Whilst Maintaining Efficacy. In: BLOOD. (pp. 1797 - 1797).

Raj, D; Peggs, K; Pule, M; Linch, D; Davies, M; Nathwani, A; (2011) Adoptive immunotherapy for patients with chronic lymphocytic leukaemia using a chimeric antigen receptor targeting CD23. In: HUMAN GENE THERAPY. (pp. A120 - A121). MARY ANN LIEBERT INC

Rashid, ST; Yusa, K; Strick-Marchand, H; Rouhani, F; Miranda, E; Hannan, NR; ... Vallier, L; + view all (2011) TOWARDS CELL BASED THERAPY FOR alpha 1-ANTITRYPSIN DEFICIENCY THROUGH TARGETED BI-ALLELIC GENE CORRECTION IN HUMAN IPS CELLS. In: HEPATOLOGY. (pp. 421A - 421A).

Rashid, TG; Smith, TB; Prasad, AK; Dudderidge, TJ; Christmas, TJ; (2011) Eponymous Anonymous: the men behind the names. In: BJU INTERNATIONAL. (pp. 65 - 65). WILEY-BLACKWELL


Simmonds, N; Bates, AW; (2011) Reporting Paneth Cell Metaplasia in Paediatric GI Biopsies: An Audit on Current Practice and Review of Guidelines. In: JOURNAL OF PATHOLOGY. (pp. S19 - S19). WILEY-BLACKWELL

Steele, AJ; Prentice, AG; Last, V; Hoffbrand, AV; Wickremasinghe, RG; (2011) The p90RSK Inhibitor BI-D1870 Induces Apoptosis in CLL Cells. In: BLOOD. (pp. 1067 - 1067).

Taher, AT; Porter, JB; Viprakasit, V; Kattamis, A; Chuncharunee, S; Sutcharitchan, P; ... Cappellini, MD; + view all (2011) Deferasirox Significantly Reduces Liver Iron Concentration In Non-Transfusion-Dependent Thalassemia Patients with Iron Overload: Results From the 1-Year Randomized, Double-Blind, Placebo-Controlled Phase II THALASSA Study. In: BLOOD. (pp. 412 - 413).

Tavarozzi, F; Mayor, NP; Cooke, L; Madrigal, JA; Marsh, SGE; Shaw, BE; (2011) Impact of HLA-DPA1 matching status on outcome, following unrelated donor hematopoietic stem cell transplantation, in the context of a 10/10 HLA-matched background. In: TISSUE ANTIGENS. (pp. 381 - 381). WILEY-BLACKWELL

Thomas, MR; Machin, SJ; Mackie, I; Scully, MA; (2011) B cell-activating factor (BAFF) is elevated in acute idiopathic thrombotic thrombocytopenic purpura (TTP). In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 8 - 8).

Tsogka, E; Brazma, D; Howard-Reeves, J; Grace, C; Nacheva, EP; (2011) MOLECULAR Karyotyping In CLL - COST Neutral Alternative to FISH SCREENING for Detection of Clinically Relevant Genome Imbalances. In: BLOOD. (pp. 1520 - 1520).

Tulpule, S; Russell, NH; Byrne, J; Das-Gupta, EP; Ethell, ME; Figueroa, D; ... Shaw, BE; + view all (2011) High Absolute T Regulatory Cell Counts and Resistance of CD8 Central Memory Cells to Killing by Fludarabine Predicts for Poor Responses to DLI in the Context of a Pre-DLI Lymphoreduction, Strategy. In: BLOOD. (pp. 834 - 834).

van der Pol, E; Gardiner, C; Harrison, P; Grootemaat, AE; Sturk, A; van Leeuwen, TG; Nieuwland, R; (2011) Size distribution and concentration of microparticles and exosomes determined by advanced optical and non-optical detection methods. In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. (pp. 184 - 184).

Virgilio, M; Payne, E; Narla, A; Sun, H; Paw, BH; Look, T; ... Khanna-Gupta, A; + view all (2011) L-Leucine Improves the Anemia of the 5q-Syndrome Via Activation of the mTOR (mammalian target of rapamycin) Pathway. In: BLOOD. (pp. 443 - 444).

Weinreb, N; Belmatoug, N; Bembi, B; Bodamer, O; Cappellini, MD; Deegan, PB; ... Therapeutic Goals MAP Taskforce,; + view all (2011) A novel tool for mapping disease severity and outcomes in patients with Gaucher disease utilising the therapeutic goals. In: MOLECULAR GENETICS AND METABOLISM. (pp. S46 - S46). ACADEMIC PRESS INC ELSEVIER SCIENCE

Whitmore, C; Ackroyd, MR; Ashraf, A; Alyoshkin, B; Muntoni, F; Brown, SC; (2011) Generation of a new mouse model for therapeutic testing in the dystroglycanopathies. In: NEUROMUSCULAR DISORDERS. (pp. 664 - 664). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Brown, SC; (2011) Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease. In: NEUROMUSCULAR DISORDERS. (pp. 665 - 665). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Brown, SC; (2011) Deposition of the inner limiting membrane in the eye of a mouse model for Muscle Eye Brain disease. In: NEUROMUSCULAR DISORDERS. (pp. S11 - S11). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Ashraf, A; Muntoni, F; Brown, SC; (2011) Generation of a new mouse model for therapeutic testing in the dystroglycanopathies. In: NEUROMUSCULAR DISORDERS. (pp. S10 - S10). PERGAMON-ELSEVIER SCIENCE LTD

Whitmore, C; Ackroyd, MR; Muses, S; Ashraf, A; Muntoni, F; Brown, SC; Wells, DJ; (2011) Assessing the therapeutic potential of LARGE in a new mouse model of dystroglycanopathy. In: NEUROMUSCULAR DISORDERS. (pp. 665 - 665). PERGAMON-ELSEVIER SCIENCE LTD

This list was generated on Sun Jun 28 04:01:56 2015 BST.